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ABSTRACT 
 
Proper autonomic regulation of mammalian cardiac function is dependent 
upon very complex and precise communication among the intracardiac ganglia 
and individual neurons within the ganglia.  An array of neuromodulators is found 
within the ganglia that direct neuronal activity by modulating the movement of 
calcium.  The current study determines that opioidergic agonists, which have 
been found to contribute to severe cardiac disease states and intracellular 
calcium mobilization, are also responsible for changes in the function of the 
intracardiac neuron via their effects on store-operated calcium channels (SOCs).    
Previous studies suggest that phosphorylation plays a role in SOC 
regulation. Using Fura-2 calcium fluorometry, we determined that protein kinase 
A (PKA), protein kinase C (PKC), and cyclic adenosine monophosphate (cAMP) 
had no effect on store-operated calcium entry in the presence of antagonists, 
phorbol 12, 13 dibutyrate (PDBu), forskolin, and 8-Br cAMP, respectively. We 
also found pharmacologically that using both electrophysiology and calcium 
imaging that µ-opioid agonists, met-enkephalin (ME) and endomorphin (EM) 
depress SOC activity in intracardiac neurons.       Arachidonic acid (AA), which 
viii 
 
has been found to depress SOC function in rat liver cells and µ-opioid receptor 
activation (MOR), blocked both store-operated calcium entry (SOCE) and the 
calcium release-activated current (ICRAC) significantly.  Contrastingly, AA 
metabolites, prostaglandin E2 (PGE2) and prostaglandin D2 (PGD2), do not 
significantly influence SOCE which suggests that the effects of AA may be direct.   
The block elicited by EM was partially reversed by pertussis toxin (PTX), 
indicative of activation of a PTX-sensitive G-protein following MOR activation. 
Similarly, PLA2 inhibitors, OBAA and AACOCF3, decreased the percent block of 
SOCE due to opioid agonist-induced inhibition.      
   Using the perforated-patch method of I-clamp electrophysiology, we 
demonstrated that gadolinium, at low micromolar concentrations, reversibly 
reduced action potential firing.   Importantly, these results suggest that SOCs 
may influence action potential firing in mammalian intracardiac neurons.   
Similarly, AA and EM depressed action potential firing.  Taken together, these 
experiments suggest that a pathway involving EM and AA influences repetitive 
firing through SOC inhibition.    
The importance of SOCs in the maintenance of action potential firing and 
more specifically, the expression and biophysical functionality of the individual 
pore-forming subunits (Orai1, 2, and 3) in any neuronal cell type has previously 
not been explored.   Quantitative RT-PCR along with I-clamp electrophysiology 
revealed that Orai3 was exclusive to repetitively firing neurons. As a result, we 
ix 
 
hypothesize that robust Ca2+-dependent fast inactivation, also associated Orai3, 
is a factor in the maintenance of repetitive action potential firing.    
 Using Fura-2 calcium fluorometry and patch-clamp electrophysiology, we 
determined pharmacologically that µ-opioid receptor activation precedes an 
intracellular cascade that is dependent on a PTX-sensitive G-protein and AA but 
independent of prostaglandin and protein kinase activity. Finally, we used RT-
PCR to determine the Orai subunits expressed in the intracardiac neurons and 
their influence on neuronal firing patterns.   This study is the first to determine the 
role expressed subunits has in the maintenance of the electrical activity of the 
neuron.   
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CHAPTER 1 
 
BACKGROUND AND SIGNIFICANCE 
 
Mammalian Intracardiac Ganglia 
The mammalian intracardiac ganglia are composed of clusters of efferent 
and afferent neurons that serve as the final common pathway for autonomic 
control of cardiac function.  Mediating all parasympathetic input to the heart, 
these ganglia receive input from the dorsal motor nucleus (DMN) and nucleus 
ambiguus (NA) via ipsilateral fibers of the right and left vagal nerves (cranial 
nerve X) (Standish, Enquist et al. 1994).  Located superficially on the epicardium 
within adipose tissue and embedded within the septum between the two atria, the 
epicardial and intraseptal ganglion, control the sinoatrial (SA) and atrioventricular 
(AV) nodes, the cardiac myocytes, and the coronary vasculature (Figure 1.1) 
(Cuevas 1995) (Ardell and Randall 1986; Randall, Milosavljevic et al. 1986). 
 Each disparate cluster within the cardiac plexus receives input from 
separate regions of the CNS for specialized coordination of cardiac function.  For 
instance, the SA ganglion, situated at the junction of the right pulmonary vein and 
left atrial junction, receives input from the NA resulting in a negative chronotropic 
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effect (Gatti, Johnson et al. 1995; Massari, Johnson et al. 1994; Massari, 
Johnson et al. 1995). Conversely, the AV ganglion, located at the junction of the 
left atrium and inferior vena cava, receives input from both the DMN and NA to 
elicit a negative dromotropic effect (Standish, Enquist et al. 1995; Gatti, Johnson 
et al. 1995; Massari, Johnson et al.1994; Massari, Johnson et al. 1995).     
The ganglia seem to be interconnected within the plexus by a network of 
nerve fibers, permitting interganglionic communication (Pardini, Patel et al. 
1987).  The distribution and quantity of ganglia are different among mammalian 
species.  For example, there are four ganglionic clusters in the atria and three in 
the ventricles of the dog whereas there are four ganglionic cluster groups totaling 
4000 neurons in the atria of the rat heart (Fig 1.2) (Armour and Hopkins 1990; Xu 
and Adams 1992).   
The intrinsic cardiac nerve plexus is by no means a simple relay system 
like some other autonomic efferent pathways (Gray, Johnson et al. 2004). 
Emerging studies conclude that this circuit is a part of a ranked series of 
intrathoracic nested feedback loops including interneurons, afferents, 
parasympathetic and sympathetic postganglionic efferent neurons, enabling rapid 
and  precise orchestration of cardiac outputs (Ardell, Randall et al. 1988). 
Furthermore, the complex morphology of the intracardiac ganglia, representative 
of the organ level of the hierarchy of the cardiac nervous system, strongly 
suggests that it acts as a major local integration center.  This neurocircuitry  
receives mechanical and chemical information from atrial and ventricular origins, 
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thus maintaining interganglionic neuronal communication that is also capable of 
regulation of reflex short-loop and extracardiac sensory feedback (Fig 1.3) 
(Cuevas 1995).    
  These various pathways function concomitantly to provide beat-to-beat 
regulation of the heart. However the intracardiac ganglia are responsible for 
integrating the information from these feedback loops spatially and temporally for 
precise and accurate output (Armour 1999).  Input from the CNS is not 
mandatory for the activity of this plexus. Following chronic decentralization of the 
heart, neural communication returns and management of activities such as 
contractility, especially, are resumed (Ardell, Butler et al. 1991).   The anatomical 
structure of the rat intracardiac plexus is similar to that of the human. Therefore, 
the rat is an accurate model for the experiments outlined in this dissertation.  The 
guinea pig cardiac plexus has smaller clusters consisting of about 20 cells 
whereas the human and rat have clusters of about 200 cells.   These neurons are 
more densely populated in the septum in comparison to the atrial walls.   
Specifically, more ganglionic neurons are situated near the SA node in the left 
atrium than in the right (Leger, Croll et al. 1999).   The rat has four distinct 
regions: between the superior vena cava and aorta, within  the superior interatrial 
septum,   posterior to the left atrium and the posterior to the inferior interatrial 
septum  and right atrium (Pardini, Patel et al. 1987).   
Functionally, there are three types of neurons in the intracardiac ganglia: 
principal parasympathetic efferent postganglionic neurons (P), interneurons (IN) 
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that provide intraganglionic and interganglionic communication, and 
catacholaminergic small, intensely fluorescent cells (SIF) (Xi, Randall et al. 
1991).    Principal neurons receive inputs from the CNS, afferent neurons, 
sympathetic nerve fibers, INs, and SIFs and synapse on SA and AV nodes, the 
myocardium, and the coronary arteries.  Receiving inputs from the CNS and 
sympathetic efferents, IN synapse on the P and SIF, which release 
catecholamines on P (Seabrook, Fieber et al. 1990).  In addition, there are 
afferent neurons that extend from the ganglia to the central nervous system.  
Furthermore, in addition to functionality, these neurons are 
morphologically distinct as well.  Parasympathetic neurons are usually multipolar 
with elongated processes, whereas interneurons are either monopolar or 
pseudopolar in appearance (Edwards, Hirst et al. 1995).  These cells may also 
be categorized by soma diameter as well, with IN being the larger and SIF  
having the smallest diameter (Allen and Burnstock 1987; Seabrook, Fieber et al. 
1990). 
Every cell has a distinct electrical discharge characteristic in addition to 
distinct morphological and functional characteristics.  In the pig, three distinct 
firing patterns have been confirmed: I (phasic), II (accommodating), and III (tonic) 
(Smith 1999).  In the canine, action potential trains have been described as S, R, 
and N, corresponding to phasic firing, tonic firing, and neurons void of firing 
activity, respectively (Xi, Thomas et al. 1991; Xi, Randall et al. 1994).     
Applicable to the current study, rat cardiac neurons possess three main 
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ganglionic neuronal types, Ib, Im,   and II.  However, there is some heterogeneity 
associated with these three types.  Ib elicits adapting firing patters, Im exhibits 
tonic firing and Type II is capable of both phasic and tonic firing (Selyanko 1992).    
The intracardiac plexus has a complex neurohumoral component in 
addition to its complex neural network. Indicative of acetylcholine (ACh) 
dominance as a neurotransmitter, choline acetyl transferase (ChAT) 
immunoreactivity is present in all postganglionic cells of the guinea pig intrinsic 
cardiac ganglia (Mawe, Talmage et al. 1996).    A wide variety of 
neurotransmitters and neuropeptides are present in the intrinsic and extrinsic 
fibers found within the ganglia and ultimately affect neurons and target tissue. 
Neurotransmitters such as ACh, norepinephrine, and dopamine and 
neuropeptides such as pituitary adenylate cyclase-activating peptide  (PACAP), 
vasoactive intestinal polypeptide (VIP), substance  P, calcitonin gene-related 
peptide (CGRP),  calbindin,  and neuropeptide Y found within the ganglia govern 
the electrical properties of the neurons and in turn,  the downstream organs are 
influenced (Gordon, Polak et al. 1993).   There also seems to be subpopulations 
of cells within the ganglion displaying common functionality based on 
immunoreactivity implicating similar neurochemistries within a subpopulation.  
For instance, three distinct neurochemical profiles have been identified within the 
guinea pig intracardiac ganglion: ChAT/NPY, ChAT/NPY/calbindin and 
ChAT/NPY/NOS (Richardson, Grkovic et al. 2003).   
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The study presented here is partially based on the presence of 
enkephalin-like activity in the rat heart and the hypothesis that it alters 
parasympathetic control over the effector tissues (Hughes, Kosterlitz et al. 1977; 
Richardson, Grkovic et al. 2003).   
 
Autonomic Dysfunction and Heart Disease 
It is well established that in cardiovascular disease states parasympathetic 
drive is compromised. For example, in early stages of heart failure (HF), changes 
in vagal discharge can be detected, but the exact mechanism by which this 
occurs has not been fully described (Kinugawa and Dibner-Dunlap 1995). Under 
normal conditions, the parasympathetic and sympathetic nervous systems 
interact by accentuated antagonism in which parasympathetic activation induces 
sympathetic depression.  In healthy human subjects, echocardiogram R-R 
intervals are augmented in response to subnormal doses of atropine. However, 
in the case of HF patients,  the effect of atropine on R-R intervals are significantly 
reduced a phenomenon indicative of attenuated parasympathetic control.   
Epidemiological studies indicate that decreased parasympathetic tone 
leads to an increased resting heart rate and a poorer prognosis in heart failure 
patients (Fox, Borer et al. 2007).    A reduction in parasympathetic tone, coupled 
with an increase in sympathetic tone, leads to an increase risk for ventricular 
tachycardia, fibrillation, and ultimately sudden cardiac death (Osaka, Saitoh et al. 
1996).   It is commonly preceded by a decrease in heart rate variability, i.e. 
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deviations in R-R intervals in sinus rhythm, followed by an electrocardiograph ST 
segment shift (Pozzati, Pancaldi et al. 1996).   
  Relevant to the current study, the attenuation of parasympathetic control 
is due to a defect in communication within the intracardiac ganglia (Bibevski and 
Dunlap 1999).   Studies indicate that during heart failure, the intrinsic cardiac 
nervous system initially maintains its ability to regulate mechano- and chemo- 
sensitive inputs, extracardiac efferent neurons, as well as local circuit intrinsic 
cardiac neurons. Following disease progression, however, there is restructuring 
of the circuitry of the ganglia that blunts its modulatory functions (Arora, Cardinal 
et al. 2003).    It has been shown that following myocardial ischemia, the activity 
of the intrinsic cardiac neurons is also depressed (Huang, Ardell et al. 1993).   
Furthermore, compromised parasympathetic control is frequently associated with 
arrhythmias occurring after a myocardial infarction (Kleiger, Stein et al. 2005).  
Interestingly, there is evidence that the consequences of direct stimulation of the 
fat pads of the epicardium are a reduction in heart rate and sudden cardiac death 
in the canine (Wallick and Martin 1990). 
In situ, acute myocardial ischemia results in the progression of decreased 
soma and dendritic function elicited by the accumulation of reactive oxygen 
species (ROS) and purinergic receptor agonists.  Originating from surrounding 
ischemic myocardial tissue, these factors are then secreted into pericardial fluid 
(Huang, Sylven et al. 1993; Huang, Sylven et al. 1995; Thompson, Horackova et 
al. 1998).  There is also evidence that ganglionic transmission is enhanced in 
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response to histamine ligand binding to the H1 receptor of neuronal cells 
resulting in the activation of surrounding mast cells (Powers, Peterson et al. 
2001).  Particularly relevant to this study, cardiac vagal afferents are enhanced 
by prostaglandin and ROS-induced sensitization to bradykinin during the immune 
response in HF (Schultz 2001).   Studies show that VIP regulates vasodilation by 
binding to the VPAC receptor on intracardiac neurons and enhancing 
neuroexcitability through intracellular calcium elevations (DeHaven and Cuevas 
2004).  As a result of this altered parasympathetic regulation and subsequent 
effects, the myocardium becomes oxygen deprived, contributing to the 
progression of the disease state (Huang, Shirahase et al. 1993).   These 
examples demonstrate the contribution neurochemistry plays in the pathology of 
HF. 
The significance of this particular study lies in the paucity of information 
that exists about intrinsic cardiac nervous system, its modes of modulation, and 
contribution to proper cardiac function.  This study contributes to the 
determination of molecular mechanisms by which intracardiac neuronal activity is 
modulated by neuromodulators present within the ganglia.  Information derived 
from studies as the current is key in establishing improved understanding of the 
parasympathetic division of the autonomic nervous system and the methods by 
which it can be pharmacologically modified (Gheorghiade, van Veldhuisen et al. 
2006).  
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Calcium Regulation and Excitability of Intracardiac Neurons  
Calcium regulation plays an important role in many cell types, particularly 
neuronal cell types because of its capacity to regulate gene expression, Ca2+ 
dependent ion channels, neurotransmitter release, synaptic plasticity, and 
excitability.  However, mechanisms of intracellular calcium regulation remain to 
be fully elucidated in intracardiac neurons.  Neurotransmitters and 
neuromodulators such as acetylcholine (Adams 2004),  histamine (Hardwick, 
Kotarski et al. 2006),  ATP (Liu, Katnik et al. 2000), PACAP, and VIP (DeHaven 
and Cuevas 2004) have been shown to modify the activity of these cells by 
orchestrating  transmembrane and intracellular movement of calcium within these 
cells. In addition to plasma membrane fluxes, rat intrinsic neurons display two 
intracellular Ca2+ stores, IP3-sensitive stores and caffeine/ryanodine-sensitive 
stores (Smith and Adams 1999; Beker, Weber et al. 2003).   
Demonstrated by our group, PACAP was able to induce multiple action 
potential firing via a calcium-dependent mechanism that required calcium release 
from ryanodine-sensitive stores (DeHaven and Cuevas 2004).  PACAP and VIP 
evoke both a transient as well as sustained phases of cytosolic calcium entry 
following VPAC receptor activation.    The transient phase is calcium release 
from ryanodine-sensitive stores and the sustained phase is calcium entry through 
store-operated calcium channels (SOCs) in neonatal rat intracardiac neurons.  
VPAC receptor-dependent membrane depolarizations were observed in the 
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presence of both VIP and PACAP.  In contrast, studies in guinea pig intracardiac 
neurons indicate that neither VIP of PACAP induces the transient phase of 
intracellular calcium increases. Furthermore, it is the sustained phase not store-
release that is responsible for any changes in excitability elicited by PACAP 
(Tompkins, Hardwick et al. 2006).   Taken together, these results are indicative of 
differential and specific cellular physiological responses following neuropeptide 
ligand binding, justifying the necessity of extensive exploration of intracellular 
signaling mechanisms within each species.  To date, most of the information that 
exists regarding calcium homeostasis involves voltage-gated calcium channels 
as the cardinal supplier of calcium to these cells in the maintenance of 
excitability.  Furthermore, modulation of these channels leads to neurochemical 
changes in the guinea pig parasympathetic cardiac ganglia.  For instance, a 
decrease in somatostatin gene expression has been attributed to PACAP-
dependent Ca2+ influx through L-type channels.  This finding serves as evidence 
of the importance of Ca2+ as it relates to its influences on the neurochemical 
composition as well as the electrical activity of the ganglia (Braas, Rossignol et 
al. 2004).  
Muscarinic as well as nicotinic synergistic receptor activation leads to   
calcium release from IP3 and ryanodine sensitive stores in rat autonomic 
neurons.  Cholinergic receptor activation is capable of converting excitability 
through membrane depolarizations and Ca2+-dependent K+ channels (KCa2+) 
(Beker, Weber et al. 2003).    In addition to Ca2+-induced membrane 
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depolarization, Ca2+-dependent ion channels contribute to the membrane 
properties of these cells.  Particularly, KCa2+ channels have been identified and 
their function and biophysical properties have been described using 
electrophysiology (Xu and Adams 1992; Xi-Moy and Dun 1995; Franciolini, Hogg 
et al. 2001). 
  Even though at least three types of depolarization-activated calcium 
channels have been identified in intracardiac neurons, action potential firing 
occurs quite independently of voltage-gated calcium channel activity (Franciolini, 
Hogg et al. 2001). Therefore, there must be a depolarization-independent 
component to calcium influx in intracardiac neurons because bath applied, 
voltage-gated calcium channel blocker, Cd2+ is unsuccessful in significantly 
reducing action potential or after-hyperpolarization (AHP).  It is therefore possible 
that this component is store-operated (Franciolini, Hogg et al. 2001). 
 
 
Store-Operated Calcium Channels 
Acutely dissociated adult rat intracardiac neurons express four different 
subtypes of HVA (high voltage –activated) Ca2+ channels with total contribution 
to the total voltage current being in the order of N (63%) > Q (19%) > L (11%) >R 
(7%) (Jeong and Wurster 1997).   Franciolini et al. report that selective block of 
the V-gated calcium channel has no significant effect on the action potential or 
duration of the AHP within intracardiac neurons (2001). The defining 
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characteristic of SOCs is their ability to activate in response to the depletion of 
calcium from the endoplasmic reticulum.  Calcium influx through these channels 
embedded within the plasma membrane then replenishes endoplasmic reticulum 
(ER) calcium.   Primarily, the ER acts as an intracellular sink for Ca2+, and Ca2+ 
itself is essential for the proper folding of proteins. It also plays a role in various 
processes, such as vesicular trafficking and cholesterol metabolism, and is a 
ubiquitous second messenger. When the Ca2+ concentration within the lumen of 
the ER falls too low, ER stress occurs and may result in apoptosis (Ferri and 
Kroemer 2001).  SOCs are capable of refilling the intracellular stores, preserving 
protein production, folding, and trafficking (Parekh and Putney 2005). 
Capacitative calcium entry (CCE) or store operated calcium entry (SOCE) in 
response to intracellular store depletion is important for cell survival and function 
of both excitable and non-excitable cell types (Xue, Zhao et al. 2000; Weigl, Zidar 
et al. 2003). 
To date, the best characterized SOC channel is the channel mediating 
calcium release activating current (ICRAC).  Analogous to SOCE, ICRAC is evoked 
following passive calcium store depletion and inwardly-rectifying given its current- 
voltage relationship.  After completing a 1-2s voltage ramp from -100mV to 
+100mV and returning to a depolarized potential (0 mV), the driving force for 
Ca2+ ions is greatly reduced (Penner, Matthews et al. 1988; Lewis and Cahalan 
1989; Bird, DeHaven et al. 2008).   Under physiological conditions the CRAC 
channel has significantly high conductance for Ca2+ over monovalent ion species 
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indicated by its large amplitude at negative potentials and near zero at positive 
amplitudes (>60 mV).  However, ICRAC becomes highly selective for Na+ ions in 
the absence of Ca2+, potentiating the current (Parekh and Putney 2005; Bird, 
DeHaven et al. 2008).   Furthermore, the CRAC channel has an allosteric binding 
site for Ca2+ ions therefore at nanomolar concentrations the ICRAC is inhibited.  
The pore-forming subunit of the SOC channel, Orai1 or CRACM1, was 
first identified as non-functional in immune cells of severe combined immune 
deficiency (SCID) patients (Feske, Gwack et al. 2006). Two other Orai1 
homologs, Orai2 and 3, exist with efficacies in the order of Orai1>Orai2> Orai3, 
all capable of regulating and constituting SOCs.  The functional properties of 
these channel subunits differ from one to another.  For instance, Orai1 exhibits 
robust fast Ca2+-dependent inactivation whereas Orai2 & 3 do not display fast 
Ca2+-dependent inactivation in stably transfected HEK293 cells (Table 1)(Lis, 
Peinelt et al. 2007).   
  Their Orai1-containing channels (Orai1-SOC) are activated in response 
to a signal generated by the ER calcium sensor STIM1 (Roos, DiGregorio et al. 
2005; Spassova, Soboloff et al. 2006).   Stim possesses an ER luminal helix-
turn-helix Ca2+-sensing EF-hand, “E” and “F” representing the two helixes of the 
Ca2+- binding portion of the protein.  When ER concentrations fall below 300 µM, 
Stim1 oligomerizes and translocates near Orai1 embedded the plasma 
membrane to initiate transmembrane entry of extracellular Ca2+ (Liou, Kim et al. 
2005; Wu, Buchanan et al. 2006).  Stim2 however inhibits SOCE only after 
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coexpression with Stim1 which is indicative the formation of heteromeric puncta 
formation (Soboloff, Spassova et al. 2006). 
Intracardiac neurons, specifically, display a biphasic Ca2+ response to 
PACAP and VIP application that is indicative of store release and subsequent 
reentry.  More specifically, using the ratiometric calcium imaging along with the 
add back protocol, we have shown that SOC antagonists such as SKF-96365 
and 2- aminoethoxydiphenyl borate (2-APB) and most importantly, Gd2+, are all 
capable of reducing [Ca2+]i  during bath application of Ca2+  following passive 
store depletion caused by thapsigargin.  Subsequent whole cell 
electrophysiological studies indicate that the presence of the ICRAC using precisely 
controlled conditions specific for this relatively elusive current. After evoking the 
current, application of 5 µM Gd2+ was able to block this current appreciably.  
Molecular studies using RT-PCR also indicate the expression of Orai1 mRNA 
transcripts in neonatal rat intracardiac neurons. However Orai2 and 3 
expressions have not been confirmed prior to the current study.  
The one conundrum that investigators are confronted with in the study of 
SOCs is that there is not currently an exclusive SOC antagonist.  One antagonist, 
gadolinium, blocks receptor-operated calcium channels (ROCCs) and SOCs. 
However the differentiation lies within the differences in inhibitory concentrations. 
Store-operated calcium entry, specifically, is depressed by Gd3+ at 
concentrations under 10 µM. Other inhibitors such as 2-APB and SKF-96935 
inhibit voltage-dependent Ca2+ channels at similar concentrations.  As a result 
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Gd2+, at micromolar concentrations, is accepted as the most selective SOC 
antagonist to date (Franzius, Hoth et al. 1994). 
From one Orai subunit to the next, the pharmacology of each is distinct. 
For instance, SOC antagonist, 2-APB significantly blocks Orai1 directly and 
prevents Stim1 puncta formation.   In the case of Orai2, 2-APB elicits inhibition to 
a lesser degree than Orai1 whereas, it potentiates Orai3 in HEK 293 cells 
transiently transfected with the Orai and Stim (Table 1).  Furthermore, we must 
conclude that 2-APB acts through very intricate mechanisms in the regulation of 
SOC channels in the exploration of this relatively novel ion channel (DeHaven, 
Smyth et al. 2008).    A Stim1 homolog, Stim2, exhibits dual modes of SOC 
regulation by store and calmodulin (CaM) dependence.  CaM is proposed to 
have a dual inhibitory role first by its interaction with the Orai-Stim complex and 
inhibition of the IP3 receptor (Parvez, Beck et al. 2008).    
While these channels have been studied to some extent in non-excitable 
cells, little is known about the functional properties and cellular role of Orai1-SOC 
in neurons.  In dorsal root ganglion neurons, a Ca2+ current has been evoked 
following ER store depletion and blocked by 2 µM Ni2+ at hyperpolarized 
potentials (Usachev and Thayer 1999).   For the first time in a neuronal subtype, 
our group has successfully confirmed molecularly and pharmacologically the 
presence of functional SOCs. Therefore we propose that SOCs may be as 
integral as V-gated calcium channels in the regulation of Ca2+-dependent 
potassium channels thereby influencing cell-to-cell communication within the 
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intracardiac ganglia.  Additionally, the current study is based on the premise that 
Orai- SOCs are functionally expressed in neonatal rat intracardiac neurons and 
µ-opioid receptors purported to be expressed in this neuronal cell type regulate 
SOC channel activity.     
 
µ-opioid Receptor Activation  
Enkephalins and dynorphins are two classes of opioid agonists that are 
endogenous to the heart and are potent regulators of cardiac function.   
Enkephalins have negative effects on heart rate, contractility, and electrical 
conduction at synapses of vagal preganglionic neurons as well as other targets 
within the central and peripheral nervous system (Blinder, Johnson et al. 2005; 
Caffrey, Gaugl et al. 1985).  Under normal conditions in the adult mammalian 
heart, the mRNA encoding for the precursors proteins proenkephalins and 
prodynorphins are readily detected, but the processed protein end products are 
sparse (Springhorn and Claycomb 1992; Boluyt, Younes et al. 1993; Caffrey, 
Boluyt et al. 1994; Barlow, Deo et al. 2006).  However, endogenous as well as 
circulating opioids are elevated in individuals with genetic hypertension, 
myocardial infarction, and cardiomyopathy and in cardiac transplant patients 
(Dumont, Ouellette et al. 1991; Ationu, Sorensen et al. 1993; Barlow, Deo et al. 
2006).  Circulating opioids, specifically, are elevated in patients with congestive 
heart failure, leading to the exacerbation of the disease state by reducing cardiac 
17 
 
output (Liang, Imai et al. 1987; Fontana, Bernardi et al. 1993; Barlow, Deo et al. 
2006).   
Opioid antagonist U50,488H promotes bradycardia, arrhythmias, and 
hypotension associated with myocardial ischemia (Lee, Chen et al. 1992).  In a 
clinical study, met-enkephalin (ME) administered to a group of patients with 
neurocirculartory dystonia,   myocardial ischemia and arterial hypertension nearly 
doubled sinus node recovery time and shortened the cardiac cycle (Osadchii, 
Abushkevich et al. 2001). Taken together these studies indicated that as 
parasympathetic mediators regulating heart rate primarily, intracardiac neurons 
could possibly be affected by endorphin activity.    
Enkephalins injected centrally in the NA and locally in vagal preganglionic 
nerve fibers have cardioinhibitory effects.  (Laubie, Schmitt et al. 1979; Wu and 
Martin 1983; Blinder, Johnson et al. 2005).  Independently, this evidence 
overwhelmingly suggests that similar effects will be seen in postganglionic 
intracardiac neurons. On the other hand, opioids are capable of inhibiting 
catecholamine release and simultaneously being produced in dissociated cardiac 
myocytes by adrenergic second messengers.  Autonomic cross talk is mediated 
thereby limiting end-organ responses to nerve stimulation through this opioid-
induced feedforward effect (Barron and Hexum 1986; Wong and Lee 1987; 
Wong, Lee et al. 1990).   The exact mechanisms by which opioids exert their 
effects at the tissue and cellular level to produce these cardiovascular effects are 
poorly understood. 
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An additional method of opioid-induced modulation of the nervous system 
is via ion channels, specifically, calcium channels.   Previous studies have 
identified opioid receptor agonists as modulators of ion channels particularly, 
VGCCs.  In parasympathetic neurons of the NA, µ-opioid receptor (MOR) 
activation  has been shown to inhibit voltage-gated calcium channels and the rat 
superior cervical ganglion, respectively (Liu and Rittenhouse 2003). Based upon 
these findings, opioids may be capable of regulating the activity of the ganglia by 
modulating calcium channels, specifically.    
Pharmacologically, opioidergic agonists function, partly, in the attenuation 
of pain by reducing pre-synaptic neurotransmitter release, which is dependent 
upon Ca2+ currents (Jessell 1977; Wilding, Womack et al. 1995).    In adult rat 
ventricular myocytes, leu-enkephalin dampens L-type calcium channel activity 
leading to a reduction in the ionotropic response (Xiao, Spurgeon et al. 1993).  
The greatest contributor to the voltage-gated calcium current (ICaV) in adult rat 
intracardiac neurons, N-type calcium current is significantly reduced by µ-opioid 
specific agonist, ME, in a reduction of the amplitude of the single action potential 
waveform (Adams and Trequattrini 1998). Also, leu-enkephalin reduces 
contraction amplitudes in ventricular myocytes through the blockade of L-type 
calcium channels (Xiao, Spurgeon et al. 1993).    
 Intracellular pathways are initiated which activate and produce second 
messengers that the direct consequences on  ion channel activity.     Through G-
protein recruitment, the PLC-IP3/DAG and AC-cAMP pathways are initiated and 
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orchestrate intracellular calcium store release (Johnson, Wang et al. 1994).   
Relevant to the current study, the Adams group has proposed that opioid ligands 
induce IP3-mediated calcium mobilization (Smith and Adams 1999) as well as 
block VGCCs in rat intracardiac ganglion neurons (Adams and Trequattrini 
1998).  Taken together, it is possible that these agonists may activate an 
intracellular signaling cascade targeting SOC channels. 
  Given that G-protein recruitment precedes voltage-gated calcium current 
inhibition in NG-108 cells transfected with cloned µ-opioid receptors, this study 
aims to explore the role of G-proteins in an intracellular second messenger 
system resulting in SOC depression in cardiac neurons (Higashida, Hoshi et al. 
1998).  Furthermore, MOR activates phospholipase A2 (PLA2), the enzyme 
responsible for production of the intracellular second messenger AA in pyramidal 
neurons (Faber and Sah 2004). This finding is relevant to the present study 
because AA has been shown to be the signaling molecule responsible for SOC 
inhibition in rat liver cells. This study is novel because it attempts to establish a 
link among G-protein, PLA2, AA activation and SOC activity reduction in an 
excitable cell type.    
Under normal conditions in mammalian cardiac tissue, unesterified 
arachidonic acid (AA) concentration is low however following ischemia and 
reperfusion, AA is produced, having adverse effects on cardiac function (Van der 
Vusse, Reneman et al. 1997).     It is possible that these negative consequences 
are due the dampening of sarcoplasm Ca2+, voltage-gated calcium channels 
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(VGCCs), K+, and Na+ channel function (Huang, Xian et al. 1992; Honore, 
Barhanin et al. 1994; Kang and Leaf 1996). In non-excitable cells such as rat 
liver cells, AA is a highly effective inhibitor of SOC function at estimated 
physiological concentrations (Rychkov, Litjens et al. 2005). However, the effects 
of AA on SOC channels in neurons remain a mystery.  
This study was executed to explore the effect of MOR ligands, AA, and the 
possibility of the two participating in a common inhibitory pathway for SOC 
channel activity in the cardiac neuron.  It is our hypothesis that opioidergic 
receptor activation results in the PLA2-mediated production of AA only following 
G-protein recruitment in rat intracardiac neurons.   Consequently, the action 
potential discharge and intraganglionic and interganglionic function is 
compromised, resulting in altered autonomic regulation of the heart.  
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Figure 1.1 Schematic diagram of intracardiac ganglia and effector tissues.  
Note the interganglionic connections. AV, atrioventricular node; SA, sinoatrial 
node (Cuevas 1995) 
  
Figure 1.2 (A) Representative sketch of the organization of intracardiac neurons within 
the heart.  Each dot is an individual ganglion.  Superior view of LA, left atrium and RA, 
right atrium.  Scale bar, 1 
Intracardiac neurons in vivo under Hoffman modulation contrast optics, Scale bar, 40 
(C) Phase contrast photomicrograph of neurons enzymatically dissociated from rat 
cardiac ganglia and entered into culture for approximately 48 hours. Scale bar, 10
(Xu and Adams 1992) 
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Figure 1.3 Schematic diagram of the organization of intrathoracic cardiac plexus. 
R, Receptor (Cuevas 1995) 
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Table 1. Functional, Kinetic, and Pharmacological Properties of Orai 
Channels; adapted from (Lis, Peinelt et al. 2007) 
 Orai1 Orai2 Orai3 
Store-Operated Yes Yes Yes 
Activation time   
(t 1/2) 
35 + 7 s 21 + 3 s 63 + 7 s 
Ca2+-dependent 
inactivation (fast) 
 
Moderate Moderate Strong 
Ca2+-dependent 
inactivation 
(slow) 
 
Strong None None 
Ca2+-dependent 
reactivation 
Yes No No 
Selectivity Ca2+>> Na+, Ba2+ Ca2+>>Na+, Ba2+ Ca2+>> Na+, Ba2+ 
Monovalent 
Permeations in 
DVF solutions 
Moderate Moderate Strong 
2-APB at 50 µM Block Reduction  Potentiation 
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CHAPTER  2 
 
RECRUITMENT OF INTRACELLULAR KINASES HAS NO APPRECIABLE 
INFLUENCE ON STORE-OPERATED CALCIUM ENTRY IN INTRINSIC 
CARDIAC NEURONS 
 
INTRODUCTION 
 
The mammalian intracardiac ganglia mediate parasympthetic input to the 
heart through very complex neural interations.  However the cellular mechanisms 
by which this neural network processes vagal input remain to be fully elucidated.   
It has been established that these ganglia serve as the final common pathway for 
the integration of a variety of exogenous inputs ultimately orchestrating end 
organ function.  Communication within the ganglia and target modualtion is highly 
dependent upon the neurochemistry of the ganglia.   Similarly, the neurochemical 
component of this plexus is also very complex and the exact mechanism by 
which these neuromodulators control the cardiac ganglia is poorly understood.   
In order to begin to fully assess the the mechanisms by which these 
neuromodulators exert their effects, we must first explore the effects on the 
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single neuron.   Neuronal excitability is determined by the  membrane properties 
of the cell, biochemical interactions between intracellular and extracellular 
molecules, and membrane-bound ion channels.   Specifically, neuropeptide-
induced calicum channel modulation has been implicated in the function of 
intracardiac neurons. For example, vasoactive intestinal poplypeptide (VIP) and 
pituitary adenylate cyclase-activating polypeptide (PACAP)  increase excitability 
of intracardiac neurons by calcium-induced membrane depolarizations (Smith 
and Adams 1999; Liu, Cuevas et al. 2000; Liu, Katnik et al. 2000; Beker, Weber 
et al. 2003; DeHaven and Cuevas 2004).      VIP exerts its effects through the 
mobilization of calcium through vasointestinal pituitary adenylate cyclase 
receptor (VPAC)  activation.  Following intracellular store release, there is a 
sustained phase of the calcium response that is blocked by store-operated 
calcium channel (SOC) antagonist 2-aminoethoxydiphenyl borate (2-APB).  
VPAC receptor activation initiates an intracellular signalling cascade that leads to 
an inositol 1, 3, 4-triphosphate (IP3) -induced store release.  Furthermore, 
previous studies  show that VIP-mediated regulation of  voltage-gated calicum 
channels (VGCCs) is cyclic adenosine monophosphate (cAMP)/ protein kinase A 
(PKA)-dependent. However, the role kinases play in SOC regulation is unclear.    
Even though VGCCs have traditionally been thought to be the primary 
excellular calcium source and modualtors of excitability in neuronal cell types, 
emerging evidence shows that  SOCs are expressed and may play role in the 
function of intracardiac neurons.   SOCs are capable of being regulated by the 
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receptor-operated intracellular second messenger systems.   Confirmed to be 
expressed in intracardiac neurons, muscarinic  (M1 and M3), P2Y2 , and PAC1, 
recruit protein kinase  C (PKC), which influences store-operated calcium entry 
(SOCE) (Strassheim and Williams 2000; Zhou, Yada et al. 2001; Dejda, Jozwiak-
Bebenista et al. 2006; Watanabe, Ohba et al. 2006).  Pituitary adenylate cyclase 
(PAC1) and VPAC2 receptors couple to adenylate cyclase (AC), which activates 
kinases.  As a consequence, these kinases modulate SOCs directly.  (Chatterjee, 
Sharma et al. 1996; Lutz, Shen et al. 1999).  
Protein amino acid sequences may be evaluated  and compared to  
kinase sequences offering a method for determining possible kinase subtypes 
that are coupled to ion channel subunits.   Using Netphosk1.0,  we have 
identified putative PKA and PKC binding sites on the  first subtype of the pore-
forming subunit of the store-operated calcium channel, Orai1. Preliminary to 
determining the functional coupling of kinases to the Orai-SOC channel,  this 
finding is also indicative of a possible kinase regulatory component of  the 
sustained phase of Ca2+ increase elicited by PACAP.    
There is some controversy that exists in the literature regarding the 
influence that kinases have on SOCE.  For instance,  PKC has been found to 
have negative effects on  capacitative calcium entry (CCE) in Drosophila 
photoreceptors and human neutrophils (Hardie, Peretz et al. 1993; Montero, 
Garcia-Sancho et al. 1994).  Studies elucidating the link between SOCE and 
endothelial cell permeability show  that myosin light-chain kinase (MLCK)  alone 
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and not   PKA or  PKC influences  this process (Norwood, Moore et al. 2000). In 
pulmonary smooth muscle  cells, PKA blocks while PKC promotes  store-
operated calcium channel function (Chen, Dai et al.).   
It is important to determine the role of these kinases in regulating SOC in 
intracardiac neurons because  electrophysiological studies done by our group  
show that SOC  function is intergral in maintaining  the  electrical activity of the 
neuron.  Known SOC antagonists,  2-APB and Gd3+,  at SOC-specific 
concentrations, attenuate  action potential firing in  intracardiac neurons, which 
suggests that repetitive firing is SOC-dependent.  
The biophysical properties of these neurons are critical  to acetyl choline 
(ACh) release, which dictates sequential cell-to-cell communication with in the 
ganglia.  These interations will ultimately influence the efficiency of the 
integration of information received by the CNS and ultimately affect cholinergic 
drive to the vasculature, myoctes, and nodal tissue of the heart.  This study 
ascertains, using fura-2 mediated calcium flurometry, that store-depletion calcium 
entry is unaffected by PKA or PKC.   
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METHODS 
 
Cell Culture 
All animals used in this study were Sprague-Dawley neonatal rats, 
sacrificed using rapid decapitation at 2-4 days old.  All procedures were done in 
accordance with the regulations of the Institutional Animal Care and Use 
Committee.   Preparation and culture of neurons were followed as previously 
described (Fieber and Adams 1991).   Enzymatically dissociated neurons were 
fixed on poly-L-lysine coated coverslips and incubated for 2-5 days in 95% air 
and 5% CO2 at 37oC.  Following cell culture, isolated neurons were used for 
calcium imaging studies.   
 
Ratiometric Calcium Fluorometry Measurements 
Fluctuations in intracellular calcium concentrations were measured using 
fluorescent imaging techniques.   Fura-2-acetoxymethylester (fura-2-AM) was 
used as the indicator to measure [Ca2+]i in the intracardiac neurons. Cells plated 
on coverslips were incubated for 1h in physiological saline solution (PSS): 140 
mM NaCl, 3 mM KCl, 2.5 mM CaCl2, 1.2 mM MgCl2, 7.7 mM glucose and 10 mM 
Hepes (pH to 7.2 with NaOH) and 3 µM fura-2-AM plus 0.1% dimethyl sulfoxide 
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(DMSO).  All solutions were administered focally via a rapid application system 
(Cuevas and Berg, 1997).   
 Methods for calcium imaging experiments were identical to those 
previously described (DeHaven and Cuevas 2004). Fluorescence emissions 
were captured using a Sensicam digital CCD camera (Cooke Corp., Auburn Hills, 
MI) and recorded using Slidebook Version 3 Software (Intelligent Imaging 
Innovations, Denver, CO).  Changes in [Ca2+]i were calculated using Slidebook 3 
software (Intelligent Imaging Innovations, Denver, CO) from the intensity of the 
emitted fluorescence following excitation with 340- and 380-nM light, respectively 
using the Grynkiewicz equation: 
 
[Ca2+]i = Kd Q(R-Rmin)/(Rmax –R)                                 (Eq.1) 
 
  
Where R denotes the fluorescence intensity ratio (F340/F380) as determined as 
a result of experiments, Q is the ratio of Fmin to Fmax at 380 nM and Kd is the Ca2+ 
dissociation constant for fura-2. Calibration of the system was performed using 
fura-2 calcium imaging calibration kit (Molecular Probes, Inc., Eugene, OR).  
These values were determined as follows: Fmin /Fmax = 224; Rmin = 0.198977; 
Rmax= 7.5354.  
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Reagents and Statistical Analysis 
 
 The following agents were used in this study: Forskolin, PDBu, 8-Br-cAMP 
(Sigma), and fura-2-AM (Molecular Probes, Inc., Eugene, OR).  Imaging data 
files were converted to text format and imported into SigmaPlot 11 and Clampfit 
9.2 for analysis.  Statistical analysis was performed by SigmaPlot using paired 
and unpaired t-tests to determine significance within a group. The differences 
between groups are significant if p<0.05. 
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RESULTS 
 
PKC activation has no influence on SOCE  
To determine whether PKC activation influences SOC activity, fura-2 
mediated calcium imaging was used to measure changes in SOCE in the 
absence and presence of PKC activation by phorbol 12, 13 dibutyrate (PDBu).    
Cells were preincubated overnight in media containing 1 µM PDBu, or in normal 
media, and population studies were used to determine the effects of PDBu on 
SOCE. The add-back protocol was initiated in fura-2 loaded neurons through the 
activation of passive depletion of intracellular Ca2+ stores by thapsigargin (TG) in 
a calcium-free PSS solution.  Baseline levels of calcium were recorded prior to 
the introduction of 2.5 mM calcium PSS to the bath.  Next, the resultant 
intracellular calcium increases were measured in neurons that had been exposed 
to 1 µM PDBu overnight and allowed to wash for 5 min and in naïve neurons in 
order to evaluate significant changes in SOCE. In Figure 2.1A, representative 
traces of intracellular calcium concentration as a function of time during Ca2+ add 
back from two neurons are shown.  The solid line is indicative of the add-back 
response in the absence of PDBu and the dashed line, the presence of PDBu.  
The intracellular increases in both control and drug treated groups were 146+10 
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nM and 150 +11 nM and were not statistically different (Figure 2.1B).   The 
results represented here suggest that the PKC activation does not influence the 
magnitude of SOCE in rat neonatal intracardiac neurons.     
 
PKA activation does not contribute to the regulation of SOCE  
 In pulmonary smooth muscle cells, PKA inhibitor H-89 activates SOCE 
(Chen, Dai et al.). Similarly, NetPhosk1.0 results indicate that Orai1 has putative 
binding sites for PKA.     To determine whether the pore-forming subunit is 
influenced by the kinase in neonatal intracardiac neurons, calcium imaging with 
the add-back protocol were used to determine the role PKA has in SOC 
modulation.  The membrane permeable cAMP analog, 8-Br-cAMP, will be used 
to mimic the effects of cAMP and activate PKA.  Fura-2 loaded cells were pre-
treated with 4 µM TG to passively deplete the stores. Mean peak calcium levels 
were recorded and analyzed before (Control) and after (cAMP) drug 
presentation.  Representative traces show qualitatively that application of 8-Br-
cAMP has no effects on SOCE, and thus, PKA is unlikely to be affecting SOC 
(Figure 2.2A).     The solid line is indicative of control conditions; while the 
dashed line is a representative trace from the same cell following 8-Br-cAMP 
application.    The bar graph in Figure 2.2B also shows the mean peak calcium 
levels for control (162 +15 nM) and drug-treated groups (151 +16 nM).  These 
groups were not statistically different.  PKA has no considerable influence on 
SOCE in neonatal rat intracardiac neurons.   
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CCE is unaffected by an AC-cAMP pathway 
   To confirm the observations made with 8-Br-cAMP, the AC-cAMP 
pathway was activated to indirectly activate PKA and determine the consequence 
this pathway has on SOCE.  Similar to aforementioned experiments, store-
depleted neurons were exposed to a calcium- PSS solution to induce intracellular 
calcium increases. In this set of experiments, forskolin, an adenylate cyclase 
activator, was applied to cells to promote the production of cAMP.    Figure 2.3 
demonstrates the outcome of experiments in which the intracellular calcium 
concentrations were assessed following add back (solid line) of calcium before 
and after adenylate cyclase-activator, forskolin (Forsk), application.     The mean 
peak calcium levels were determined to be 128 ± 8 nM for control group and 137 
± 17 nM.   Statistical analysis shows that these values are not different.   
Representative traces of changes in intracellular calcium levels in response to 
add back are shown (Figure 2.3B).     These results confirm that the AC-cAMP-
PKA pathway, similar to direct activation of PKC and PKA, have no significant 
effects CCE.   
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Figure 2.1.    PKC activation has no influence on SOCE. A, Representative 
traces of ∆[Ca2+]i for two individual neurons using the add back protocol for 
control (solid, n=59), a treatment of 1 µM PDBu (dashed, n=42). Line above 
trace represents 2.5 mM Ca2+ application. B, Bar graph of values mean (± 
SEM) Peak ∆[Ca2+]i for control, drug-treated, and wash groups for the duration 
of the add back.  There is no significant difference from control group.    
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Figure 2.2.    PKA activation does not contribute to the regulation of SOCE. A, 
Representative traces of ∆[Ca2+]i for two individual neurons using the add back 
protocol for control (solid, n=45), a treatment of 100 µM cAMP (dashed, n=27). 
Line above trace represents 2.5 mM Ca2+ application. B, Bar graph of values 
mean (± SEM) Peak ∆[Ca2+]i for control, drug-treated, and wash groups for the 
duration of the add back.  There is no significant difference from control group.    
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Figure 2.3.    CCE is unaffected by an AC-cAMP pathway. A, Representative traces of 
∆[Ca2+]i for two individual neurons using the add back protocol for control (solid, n=72), 
a treatment of 10 µM Forskolin (dashed, n=23). Line above trace represents 2.5 mM 
Ca2+ application. B, Bar graph of values mean (± SEM) Peak ∆[Ca2+]i for control, drug-
treated, and wash groups for the duration of the add back.  There is no significant 
difference from control group. 
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DISCUSSION 
 
 
 In this study, we conclude that phosphorylation by PKA and PKC has no 
appreciable effect on SOCE  in  intracardiac neurons.  This study is novel 
because published information that exists on phosphorylation of  SOCs applies to 
non-excitable cells.   This study attempts to begin to determine possible modes 
of SOC regulation in excitable cells and the contribution SOCE has on neuronal 
function.   
 First, using calcium imaging and PKC activator PDBu, we show that PKC 
does not potentiate nor does it block intracellular calcium elevations following 
store depletion in intrinsic cardiac neurons.   Our findings  concur with studies in 
other cell types, such as endothelial cells, that cite that PKC has no bearing on 
the function of SOCs  (Norwood, Moore et al. 2000) .   It is possible that  PKC 
had an indirect  effect on store-depletion versus the channel itself in previous 
studies (Berridge 1995). However, in the present investigation, stores were 
passsively  depleted   prior to experiments, consequently  this variable  was 
eliminated.    
NetPhosk analysis output results indicated that there are putative binding 
sites for PKC and PKA on the Orai1 subunit. However, NetphosK provides 
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predicted results based on the amino acid sequences and mathematics.  Further, 
binding studies would be apporiate to confirm protein-protein interaction.   
 Next we used an identical protocol, but with the membrane permeable 
cAMP analog, 8-Br-cAMP, to determine if cAMP and/or the downstream kinase, 
PKA, can affect SOC  activity in these cells.  Similarly, no appreciable differences 
in SOCE could be detected when 8-Br-cAMP was bath applied during the add 
back. Conversely, Zhou et. al. report that an AC-cAMP-PKA intracellular 
signalling cascade is initiated following  PAC1 receptor binding in neuroepithelia 
cells (2001).  These conflicting findings suggest that the effects elicited by 
kinases could be dependent upon cell type.   
 The conclusions drawn from the 8-Br-cAMP experiments were supported 
by studies using the AC activator, forskolin.  Forskolin failed to evoke any 
changes  in SOCE in this sytem.  The published data that exists linking cAMP to 
SOCE is conflicting.  In airway smooth muscle cells, cAMP blocks  SOCs (Ay, 
Iyanoye et al. 2006).  However, there is also evidence that this phenomenon 
could be due to upstream effects on the unloading of the stores.  For instance, 
histamine and ACh hydrolyze IP3 via cAMP, leading to a decrease in intracellular 
calcium mobilization, thus causing a decrease in SOC channel modulation 
(Raeymaekers, Eggermont et al. 1990). In rat aorta, cAMP is a SOC antagonist;  
while in  astrocytes cAMP acts as an agonist for SOCE (Wu, Chen et al. 1999).  
Taken together, these studies suggest that differences in kinase activity may be 
due to differences in cell type.  More cell type specific studies would need to be 
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performed to determine these differences in regulation and the factors that 
contribute to these differences.   
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CHAPTER 3 
 
µ-OPIOID RECEPTOR ACTIVATION BLOCKS SOCE AND THE ICRAC VIA AN 
ARACHIDONIC ACID MEDIATED PATHWAY IN RAT INTRACARDIAC 
NEURONS 
 
Introduction 
 
Decreased parasympathetic modulation of the diseased mammalian heart 
allows sympathetic regulation to predominate, which could lead to ventricular 
dysrhythmias and ultimately, sudden cardiac death.   The mammalian 
intracardiac ganglia are groups of parasympathetic efferent and afferent neurons 
that serve as the final common pathway to autonomic control of local cardiac 
function neurons modulating conduction, contractility, and vascular tone (Ardell 
2004).  Additionally, intrinsic cardiac neurons function locally to provide rapid 
sensory feedback and contribute to the maintenance of proper cardiac function 
independent of the CNS (Ardell 1994).   Enkephalins and dynorphins are two 
classes of opioid agonists that are endogenous to the heart and are potent 
regulators of cardiac function. Under normal conditions in the adult mammalian 
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heart, the mRNA encoding for the precursor proteins proenkephalins and 
prodynorphins are readily detected, but the processed protein end products are 
sparse (Springhorn and Claycomb 1992; Boluyt, Younes et al. 1993; Caffrey, 
Boluyt et al. 1994; Barlow, Deo et al. 2006).  However, endogenous as well as 
circulating opioids are elevated in individuals with genetic hypertension and 
cardiomyopathy and in cardiac transplant patients (Dumont, Ouellette et al. 1991; 
Ationu, Sorensen et al. 1993; Barlow, Deo et al. 2006).  Circulating opioids, 
specifically, are elevated in patients with congestive heart failure (Liang, Imai et 
al. 1987; Fontana, Bernardi et al. 1993; Barlow, Deo et al. 2006). 
 Activation of µ-opioid receptors (MOR) in these neurons produce 
elevations in [Ca2+]i but results in depression of excitability (Smith and Adams 
1999). In contrast,  two neuropeptides found within the mammalian intracardiac 
ganglion, pituitary adenylate cyclase activating peptide (PACAP) and 
vasointestinal polypeptide (VIP), have been shown to enhance the excitability of 
intracardiac neurons via a mechanism dependent on similar elevations of 
intracellular calcium concentrations ([Ca2+]i) (DeHaven and Cuevas 2004).   
Obviously, these neuromodulators exert their opposing effects on membrane 
properties of the neuron via different mechanisms.  While the MOR agonist 
depletes intracellular calcium stores, VIP and PACAP elicit a sustained [Ca2+]i 
increase, store release, that  precedes a transient intracellular calcium response, 
influx through channels on the plasma membrane.   This phenomenon is 
capacitative calcium entry (CCE) or store-operate calcium entry (SOCE); that is, 
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calcium influx regulated by Ca2+ concentrations within the cellular stores.  The 
transient phase is reduced in the presence of SOC antagonist, 50 µM 2-APB, 
which indicates that VIP and PACAP are able to evoke a SOCE response in rat 
intracardiac neurons. 
The Adams group has proposed that opioid ligands induce IP3-mediated 
calcium mobilization as well as blockade of voltage-gated calcium channels 
(VGCCs) in rat intracardiac neurons (Adams and Trequattrini 1998; Smith and 
Adams 1999).  Taken together, it is possible that these agonists may play a role 
in the function of SOC channels.  Furthermore,   Franciolini et al. report that 
selective block of the voltage-gated calcium channel has no significant effect on 
the action potential or duration of the after-hyperpolarization (AHP) within 
intracardiac neurons   (2001). In support of this study, electrophysiology 
experiments indicate that there is more than one functional type of calcium 
channel in the intracardiac neuron (Xu and Adams 1992).  While VGCCs have 
been established as the key regulator of calcium mobilization in the intracardiac 
neurons, these results suggest that SOCs may play a significant role in action 
potential firing. 
   SOCs are important because they ensure availability of calcium in 
response to depletion of intracellular stores. The most concise description of the 
current as related to SOCE is the calcium release-activating calcium current 
(ICRAC).   Evoked following passive calcium store depletion, this current was 
initially characterized in rat mast cells and human leukemic T cells (Penner, 
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Matthews et al. 1988; Lewis and Cahalan 1989).   Under physiological 
conditions, the CRAC channels have significantly high preference for Ca2+ over 
monovalent ion species however ICRAC becomes highly selective for Na+ ions in 
the absence of Ca2+ (Parekh and Putney 2005;  DeHaven, Smyth et al. 2008).  
Orai-1, one of three pore-forming subunits composing SOCs, has been shown to 
be functionally expressed in intracardiac neurons (unpublished data).  It was 
recently characterized in immune cells of severe-combined immune deficiency 
(SCID) patients that express a mutated Orai-1 protein (Carr, De Costa et al. 
1991; Feske, Prakriya et al. 2005).   However, its contribution to the function of 
the cardiovascular system is unknown.  
  It is important to understand consequences of aberrant SOC channel 
function on cellular physiology whether by changes in molecular expression or 
pharmacologically. Therefore this study is based on the premises that opioid 
peptide production is altered in certain cardiac conditions and these changes 
could in turn have detrimental consequences on ganglionic function, 
exacerbating the disease.  While the δ-opioid receptor is the predominant class 
of opioid receptor in mostly non-neuronal cardiac tissue (Wittert, Hope et al. 
1996; Zimlichman, Gefel et al. 1996; Bell, Sack et al. 2000), the MOR is of 
particular interest because recent studies in intracardiac neurons suggest that µ-
opioidergic signaling inhibits N-type calcium channels (Adams and Trequattrini 
1998).  MOR activation also leads to the recruitment of phospholipase A2 (PLA2), 
the enzyme responsible for AA production in pyramidal neurons thus altering 
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action potential discharge (Faber and Sah 2004).    In non-excitable cells such as 
rat liver cells, AA is a highly effective inhibitor of SOC function at estimated 
physiological concentrations (Rychkov, Litjens et al. 2005). MOR activation and 
AA production have been shown to inhibit voltage-gated calcium channels in 
parasympathetic neurons of the nucleus ambiguus (NA) (Irnaten, Aicher et al. 
2003) and the rat superior cervical ganglion (Liu and Rittenhouse 2003), 
respectively.  However, the effects of AA on SOC channels in neurons and 
influences on membrane properties of the neuron remain a mystery.  Previous 
studies done by our group show that two important excitatory neuromodulators, 
VIP and PACAP, act via a PTX-sensitive G-protein in intracardiac neurons (Liu, 
Cuevas et al. 2000). Additionally, in pyramidal neurons of the amygdala, it has 
been shown that a PTX-sensitive G-protein linked to the MOR receptor causes 
the activation of PLA2 when the G-protein subunits dissociate (Faber and Sah 
2004).  Relevant to the current study, we hypothesize that a G-protein is involved 
in the signaling cascade coupling MOR to SOC.    For instance, Jelson et.al 
report changes in the action potential waveform following cardiac ganglionic mast 
cell degranulation as the result of the inhibition of small-conductance calcium 
channels (SKCa2+) by prostaglandins. However it remains unclear whether 
prostaglandins inhibit the channel directly or via Ca2+ channels.  
We show that MOR ligands and arachidonic acid are involved in a 
common inhibitory pathway for SOC channel regulation in cardiac neurons and 
could possibly be influential in the neuromodulation of cardiac function.  First, 
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using ratiometric calcium imaging, we show that SOCE is attenuated by MOR 
agonists and AA and linoleic acid (LA) alike.  However these effects of MOR 
activation are reduced in the presence of the PLA2 antagonist, 4-(4- 
Octadecylalkybenzoylacrylic acid (OBAA), suggesting that AA production follows 
receptor activation in a common signaling cascade.  AA metabolites, PGE2 and 
PGD2, present in the cardiac ganglia have no apparent effects on SOC function, 
indicating that they do not function downstream of AA in the depression of SOC 
activity.   Finally, using whole-cell patch clamp electrophysiology, the ICRAC is 
reduced by AA and endomorphin-1 (EM), concluding that Orai-SOCs are the 
specific targets in the MOR-mediated intracellular pathway.      
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METHODS 
 
Cell Culture 
All animals used in this study were Sprague-Dawley neonatal rats, 
sacrificed using rapid decapitation at 2-4 days old.   All procedures were done in 
accordance with the regulations of the Institutional Animal Care and Use 
Committee.   Preparation and culture of neurons were followed as previously 
described (Fieber and Adams 1991). Enzymatically dissociated neurons were 
fixed on poly-L-lysine coated coverslips and incubated for 1-5 days in 95% air 
and 5% CO2   at 37oC.  Following cell culture, isolated neurons were used for 
both calcium imaging and electrophysiological studies.    
 
Ratiometric Calcium Fluorometry Measurements 
Fluctuations in intracellular calcium concentrations were measured using 
florescent imaging techniques.   Fura-2-acetoxymethylester (fura-2-AM), was 
used as the indicator to measure [Ca2+]i in the intracardiac neurons.  Cells plated 
on coverslips were incubated for 1hr. in physiological saline solution (PSS): 140 
mM NaCl, 3 mM KCl, 2.5 mM CaCl2, 1.2 mM MgCl2, 7.7 glucose and 10 mM 
Hepes (pH to 7.2 with NaOH) and 3µM fura-2-AM plus 0.1% dimethyl sulfoxide 
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(DMSO).  All solutions were administered focally via a rapid application system 
(Cuevas and Berg, 1997).   
   Specifications for calcium imaging experiments are as previously 
described (DeHaven and Cuevas 2004). Fluorescence emissions were captured 
using a Sensicam digital CCD camera (Cooke Corp., Auburn Hills, MI) and 
recorded using Slidebook Version 3 Software (Intelligent Imaging Innovations, 
Denver, CO).  Changes in [Ca2+]i were calculated using Slidebook 3 software 
from the intensity of the emitted fluorescence following excitation with 340- and 
380-nM light, respectively using the Grynkiewicz equation: 
 
[Ca2+]i = Kd Q(R-Rmin)/(Rmax –R)                                 (Eq.1) 
 
  
where R denotes the fluorescence intensity ratio (F340/F380) as determined as a 
result of experiments,  Q is the ratio of Fmin to Fmax at 380 nM and Kd  is the Ca2+ 
dissociation constant for fura-2. Calibration of the system was performed using 
fura-2 calcium imaging calibration kit (Molecular Probes, Inc., Eugene, OR).  
These values were determined as follows: Fmin /Fmax = 224; Rmin = 0.198977; 
Rmax= 7.5354.  
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Whole-Cell Patch Clamp Electrophysiology 
Coverslips containing neurons cultured as described above were 
transferred to a recording chamber mounted on a phase contrast microscope and 
visualized at 400X.  Intracardiac neurons were electrically accessed using whole 
cell patch clamp recording techniques as described previously (Cuevas and 
Adams 1994). Cells were exposed to normal PSS, PSS nominally calcium free 
(NCF), which contained no added CaCl2 or divalent-free PSS (DVF), which 
contained no added CaCl2 and 1 mM EDTA.  The pipette solution consisted of (in 
mM): 75 CsSO4, 55 CsCl, 10 EGTA, 5 MgSO4 and 10 Hepes.    All recordings 
were made at room temperature.  Currents were amplified and filtered using an 
Axoclamp-200B Amplifier, digitized with a 1322A DigiData digitizer (20 kHz), and 
collected using a computer running the Clampex 9.2 software (Axon Instruments, 
Inc., Foster City, CA, USA).  Data were subsequently analyzed using Clampfit 
9.2 (Axon Instruments, Inc.).  
 
Reagents and Statistical Analysis 
The following drugs were used in this study: arachidonic acid (AA) , thapsigargin  
(TG) (Alamone Labs, Jerusalem, Israel) endomorphin-1 (EM), met-enkephalin 
(ME),  PGD2 and PGE2 (Cayman Chemical, Ann Arbor, MI), OBAA (Santa Cruz, 
Santa Cruz, CA)  and  fura-2-AM (Molecular Probes, Inc., Eugene, OR).  Imaging 
data files were converted to text format and imported into SigmaPlot 11 and 
Clampfit  9.2  for analysis. Statistical analysis was performed by SigmaPlot 11 
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using paired and unpaired t-tests and Two-Way ANOVAs to determine 
significance within a group or between groups. The differences between groups 
are significant if p<0.05. 
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RESULTS 
 
Opioid Receptor Agonists Inhibit SOC Activity 
 Experiments were carried out to determine the effects of µ-opioid receptor 
activation in rat intracardiac neurons.  Intracardiac neurons were incubated in 4 
µM thapsigarin (TG), an inhibitor of sarco-endoplasmic reticulum calcium-
ATPase (SERCA), to passively deplete the endoplasmic reticulum of calcium and 
elicit CCE.  Cells were initially bathed in divalent-free PSS, followed by a 2 min 
application of normal PSS.  The subsequent increase in intracellular calcium 
concentration ([Ca2+]I)  is defined as SOCE or CCE.    Figure 3.1 shows 
quantitatively the effects of EM (D) and ME (B) on CCE and representative traces 
of [Ca2+]i at each sampling interval (A&C).     Cardiac neurons were pre-
incubated in met-enkephalin (ME), a µ-opioid specific agonist, for a minute and 
applied during the reintroduction of a 2.5 mM calcium solution (Figure 3.1 A-B).  
ME depressed SOC activity considerably, decreasing peak calcium influx from 
272 +17 nM to 107 +19 nM.   Endomorphin-1 (EM-1) was more potent than met-
enkephalin, reducing mean Peak ∆[Ca2+]i from 141+6 nM to 6+1 nM even at 1 
µM (Figure 3.1 C-D).   Pronounced effects of EM were reversible following a 
5min PSS wash (220 +11 nM).   When the two different opioid receptor ligands 
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were applied to the neurons their SOC activity was attenuated comparably. 
Therefore it is possible that the MOR is coupled to a G-protein, activating an 
inhibitory signaling cascade.  
A PTX-sensitive G-protein is Recruited Following µ-opioid Receptor 
Activation 
   Stimulation of MOR in intracardiac neurons has been shown to result in 
the activation of a PTX-sensitive G-protein.  To determine if a PTX-sensitive G 
protein couples µ-opioid receptors to SOC, we obtained values for ∆[Ca2+]i using 
the add back protocol (as previously described in Figure 3.1) before and after 
PTX-treated (200ng/µL) cells were exposed to EM.  By blocking G-protein 
activation via PTX, EM-induced depression of SOC activity was reduced, 
indicative a reduction of percent block from  control levels (Figure 3.2).  Percent 
block under control conditions was established by evaluating    ∆[Ca2+]I following 
Ca2+ add back in  naïve intracardiac neurons before and after EM application in 
the absence of PTX. As shown in Figure 3.1 C-D and Figure 3.2 A, C, and D, EM 
elicits about a 52 ±  8% block of normal CCE however in populations pre-treated 
with PTX this block was reduced to about 27 ± 9% .  This is substantial evidence 
that a PTX-sensitive G- protein is an integral component within a MOR-initiated 
inhibitory pathway that could include PLA2 initiation downstream.  
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The MOR and AA are Part of a Common Signaling Mechanism that Results 
in the Loss of SOC Function.  
Figure 3.4 includes calcium-imaging experiments that determine if this 
pathway could be a regulatory mechanism for the CCE
. 
 OBAA is unique in 
comparison to other PLA2 inhibitors because it lacks structural resemblance to 
AA itself.  Traditional PLA2 inhibitors often cause pharmacological effects similar 
to AA due to their structural similarity to AA.  Therefore cultured intracardiac 
neurons were store-depleted as previously described and   pre-incubated with 50 
µM OBAA for 1 hr and the EM-induced block of CCE was compared to control 
groups. As in Figure 3.2, control percent block was determined by measuring 
∆[Ca2+]I  before and during EM application in the absence of PTX.    The opioid 
agonist elicited a 73.96 + 4.44 % block in the absence of the inhibitor however in 
the presence of OBAA this block was reduced appreciably to 21 + 3%.   
 
Arachidonic Acid Pathway Inhibits CCE  
 
To further dissect the second messenger system linking MOR to SOC in 
intracardiac neurons, we examined the role of PLA2 in this cascade.  It is 
important to note that the PTX-sensitive Gi/o has been linked to PLA2 activation 
(Faber and Sah 2004). Representative traces of ∆[Ca2+]i and quantitative data in 
Figure 3.4 A-B  show that application 6 µM AA markedly reduces SOC activity.   
AA evokes an 80% block of CCE and this effect was readily reversible upon PSS 
wash,  tripling peak ∆[Ca2+]i levels during the add back following the low AA level 
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exposure (102 + 6 nM to  31+ 5 nM  ). Also, AA precursor linoleic acid (LA) 
decreased CCE (245 + 15 to 132 + 21).  Unlike AA, the effects of LA were not 
reversible upon wash-out using PSS (data not shown).  The effect was only 
reversible upon application of BSA (Figure 3.4C&D).       
     
 
Prostaglandins Show No Significant Effect on SOCE   
As shown in Figure 3.4, the AA pathway seems to have an appreciable 
effect calcium entry following store depletion.  Therefore, it is imperative to 
explore whether AA and/or prostaglandins have a direct effect on the SOC 
channel.  To test whether SOCs are influenced by prostaglandins, rat 
intracardiac neurons were depleted using TG as described before and mean 
peak calcium concentration was measured intracellularly following calcium add 
back in the absence and presence of PGD2 (Figure 3.5 A-B) and PGE2 (Figure 
3.5 C-D).      The results suggest that neither prostanoid has the ability to effect 
SOC channel activity.   
 
Opioid Agonists Block the ICRAC  
Whole-cell patch clamp electrophysiological experiments were used to 
gain further insight into the specific ion channel modulated by MOR.  It is 
important to note that certain conditions were followed to ensure that the ICRAC 
only,
 
as opposed to another calcium current, was evoked.  First, neurons were 
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hyperpolarized using voltage steps of -60mV to -100mV, below range for 
activation of VGCCs.  Second, stores were depleted by bath application of 10 
mM caffeine and calcium chelator EGTA (1 mM) in the pipette solution.   A 
nominally free calcium solution was able to block the current, indicative of the 
ICRAC.   
 Figure 3.6 shows a time course of the changes in mean peak current in 
response to differences in the contents of the applied bath solutions.  First, 
electrical access is gained in the 2.5 mM Ca2+ solution, then store depletion  and 
stimulation of the CRAC current is achieved using caffeine (10 mM)  in a NCF for 
about 5 min.  Then, the currents were evoked using a Na+-rich divalent free 
solution. To induce MOR activation, 1 µM EM and 10 µM ME were added to the 
bath solution.  The mean peak current is greatly diminished from -151 + 15 pA to 
-95 + 15 pA (n=6) upon application of EM and -199 + 43 pA to -82 + 16 pA with 
ME (n=5) (Figure 3.7).  Reintroduction of a DVF solution reverses this response.   
These results are similar to the changes in [Ca2+]I seen Figure 3.1.  
 
AA Inhibits the ICRAC in Intracardiac Neurons similar to Opioidergic 
Agonists   
To determine if AA can mimic the effects of MOR activation, a similar time 
course was used as in Figure 3.6 and 3.7. We applied 6 µM AA to the bath to test 
proposed SOC inhibition due to activation of an intracellular opioid signaling 
cascade.     Similar to results demonstrated in Figures 3.6 and 3.7, mean peak 
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currents were diminished from  maximum of  -116  + 16 pA  during the time 
course to -40 + 8 pA.   In addition, to eliminate the possibility that arachidonic 
acid- regulated calcium currents (ARCs) are being activated during the AA 
application, AA was added to the inhibitory NCF solution following AA depression 
of the current.  AA was unable to potentiate any calcium current in the NCF 
solution (Figure 3.9).   As previously seen in prior experiments, the NCF solution, 
even in the presence of AA, was attenuated (105 + 37 pA to 78 + 12  pA) the 
current (Figure 3.8).      
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Figure 3.1. MOR agonists depress CCE.  A, Representative traces of ∆[Ca2+]i from  a 
single neuron for before (control, solid) and after a 5 min met-enkephalin (10 µM) 
treatment (ME, dotted) for calcium add back. Line above trace represents a 2 min 2.5 
mM Ca2+ application. B, Bar graph of mean (± SEM) peak ∆[Ca2+]i for control and 
met-enkephalin (ME)- treated groups in response to calcium add-back. Asterisk above 
ME bar indicates significant difference from control condition (n=27, P < 0.001). C, 
Representative traces of ∆[Ca2+]i evoked using the add-back protocol for control 
(solid), 1 µM endomorphin-1 (EM, dotted), and following a 5 min PSS wash of the µ-
opioid receptor agonist (Wash, dashed). Line above trace represents a 2 min 2.5 mM 
Ca2+ application. D, Bar graph of mean (± SEM) values of peak ∆[Ca2+]i obtained 
using the add-back protocol and the same conditions as (C.) (n=50). Asterisk above 
EM bar indicates significant difference from control group (P < 0.001) 
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Figure 3.2. A PTX-sensitive G-protein is Recruited Following MOR Activation. A, 
Representative traces of ∆[Ca2+]i for a single neuron recorded in the absence 
(solid, PSS) and presence (dashed, EM) of 1 µM EM. Line above trace 
represents a 2 min 2.5 mM Ca2+ application.   B, Representative traces of 
∆[Ca2+]i for a single neuron exposed to 200 ng/mL overnight, PTX alone (solid, 
PTX), and PTX plus 1 µM  endomorphin-1 (dashed, PTX + EM). C. Bar graph of 
mean (± SEM) values of peak ∆[Ca2+]i obtained from cells (n=21) in PSS (black, 
PSS) in the absence (Control) and presence of endomorphin-1 or following 
preincubation (n=23) in PTX (PTX, grey) in the absence (Control) and presence 
(EM) of EM. Asterisk above EM in PSS shows significance from the PSS Control 
(P<0.05).  Pound above PTX
 in PSS shows significance from PSS (P<0.05). 
The two-Way ANOVA method of statisitical analysis was used to determine 
significance.  D, Bar graph of mean percent inhibition of peak ∆[Ca2+]i observed 
when endomorphin-1 was applied alone (PSS, n = 21) or following preincubation 
in PTX
 
(PTX+EM, n=23). Asterisk above PTX+EM bar indicates significant 
difference from PTX group (P < 0.001).   
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 Figure 3.3. OBAA Reverses MOR-Induced Inhibition of SOCE.  A, Representative 
traces of ∆[Ca2+]i for a single neuron recorded in the absence (solid, PSS) and presence 
(dashed, EM) of 10 µM EM. Line above trace represents a 2 min 2.5 mM Ca2+ 
application.  B, Representative traces of ∆[Ca2+]i for a single neuron exposed to the 
PLA2 inhibitor, 50 µM  OBAA (solid, OBAA), and the PLA2 inhibitor plus 10 µM EM 
(dashed, OBAA + EM). Cell was exposed to OBAA for 1 hr prior to the experiments 
being carried out.  C,  Bar graph of mean (± SEM) values of peak ∆[Ca2+]i obtained from 
cells (n=67) in PSS (black, PSS) in the absence (Control) and presence  of  EM or 
following preincubation (n=41) in OBAA(OBAA, grey) in the absence of EM (Control) 
and presence of EM (EM).    Asterisks above EM in PSS shows significance from the 
PSS Control (P<0.05).  Asterisk above and EM in OBAA shows significance from OBAA 
in PSS (P<0.05). Pound symbol above EM in OBAA shows significance compared to 
EM in PSS (P< 0.05).  The two-Way ANOVA method of statistical analysis was used to 
determine significance.   D, Bar graph of mean percent inhibition of peak ∆[Ca2+]i 
observed when EM  was applied alone  (n=67)  or  following preincubation in OBAA 
(n=41). Asterisk above OBAA bar indicates significant difference from Control group (P 
< 0.001). 
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Figure 3.4.    AA and LA Inhibit CCE. A, Representative traces of ∆[Ca2+]i for a 
single neuron using the add back protocol for control (solid, Control), a treatment of 
6 µM AA (dashed, AA),  and a PSS wash (dotted, Wash) for add back duration. 
Line above trace represents 2.5 mM Ca2+ application. B, Bar graph of values 
mean (± SEM) Peak ∆[Ca2+]i for control, drug-treated, and wash groups (n=15). 
Asterisk above AA and Wash bars indicate significant difference from control group 
(p <0.001).  C, Representative traces of ∆[Ca2+]I from a single neuron following Ca2+ 
add back before (solid, Control) and after LA
 
 6 µM (LA) exposure (dotted, LA) and 
following  0.05 mg/mL BSA  wash out (dashed, Wash).  D, Bar graph of values 
mean (± SEM) peak ∆[Ca2+]i for control, drug-treated, and wash groups for the 
duration of the add back (n=30). Asterisk above LA bar indicates significant 
difference from control group. 
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Figure 3.5. Prostaglandins Show No Significant Effect on SOCE.  A, Representative 
traces of ∆[Ca2+]i from  a single neuron for before (solid, control),  after a 5 min PGD2 
(1 µM) treatment (dotted, PGD2), and wash (dashed, Wash). Line above trace 
represents a 2 min 2.5 mM Ca2+ application. B, Bar graph of mean (± SEM) peak 
∆[Ca2+]i for control and PGD2 treated groups in response to calcium add-back 
(n=139). C, Representative traces of ∆[Ca2+]i evoked using the add-back protocol for 
control, 1 µM PGE2 (dotted, PGE2,), and following a 5 min PSS wash of the 
prostanoid (dashed, Wash). Line above trace represents a 2 min 2.5 mM Ca2+ 
application. D, Bar graph of mean (± SEM) values of peak ∆[Ca2+]i obtained using the 
add-back protocol and the same conditions as (C.) (n=48).  
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Figure 3.6. EM blocks the CRAC.   Mean Peak currents were measured from 
intracardiac neurons (n=6).  Electrical access was obtained in a 2.5 mM calcium-
containing bath solution with a holding current of -60 pA.  Cells were dialyzed 
with a 75 mM CsCl/ 55 mM CsSO4/ 10 mM EDTA patch pipette solution and 
stepped from -60 mV to -100 mV. Then a nominally calcium-free (NCF) solution 
containing 10 mM caffeine was applied to the bath to assist with the depletion of 
intracellular stores for 5 min.  Then, the divalent-free solution (DVF) was bath 
applied to replace any Ca2+ ions with sodium ions so that Soc activity could then 
be measured as function of current carried by Na+ ions.  The Na+- ICRAC   was 
attenuated by bath application of EM-1 (1 µM) in a DVF solution for 2 min 
following by a 2 min wash-out.  Then a nominally calcium free solution was 
applied to ensure the presence of the ICRAC only and no other current was evoked 
during the course of the recording.     
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Figure 3.7. ME blocks the CRAC current.   Mean Peak currents were measured 
from intracardiac neurons (n=5).  Electrical access was obtained in normal 2.5 
mM calcium containing bath solution with a holding current of -60 pA.  Cells 
were dialyzed with a 75 mM CsCl/ 55 mM CsSO4/ 10 mM EDTA patch pipette 
solution and stepped from -60 mV to -100 mV. Then a nominally-free calcium 
solution containing 10 mM caffeine to was used assist with the depletion of 
intracellular stores for 5 min.  Then, the divalent-free solution was bath applied 
to replace any Ca2+ ions with sodium ions. The Na+- ICRAC   was attenuated by 
bath application of ME (10 µM) in a DVF solution for 2 min following by a 2 min 
wash-out.   
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Figure  3.8. AA Inhibits the ICRAC similar to Opioidergic Agonists. Mean Peak 
currents were measured from intracardiac neurons (n=5).  Electrical access 
was obtained in normal 2.5 mM calcium containing bath solution with a holding 
current of -60 pA.   Cells were dialyzed with a 75 mM CsCl/ 55 mM CsSO4/ 10 
mM EDTA patch pipette solution and stepped from -60 mV to -100 mV. Then a 
nominally-free calcium solution containing 10 mM caffeine was used to assist 
with the depletion of intracellular stores for 5 min.  Then, the divalent-free 
solution was bath applied to replace any Ca2+ ions with sodium ions so that Soc 
activity could then be measured as function of current carried by Na+ ions.  The 
Na+- ICRAC   was attenuated by bath application of AA (3 µM) in a DVF solution 
for 2 min following by a 2 min wash-out.   
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Figure 3.9. AA Failed to Activate any Calcium Current.   Mean Peak currents 
were measured from intracardiac neurons (n=5).  Electrical access was obtained 
in normal 2.5 mM calcium containing bath solution with a holding current of -60 
pA.  Cells were dialyzed with a 75 mM CsCl/ 55 mM CsSO4/ 10 mM EDTA patch 
pipette solution and stepped from -60 mV to -100 mV. Then a nominally-free 
calcium solution containing 10 mM caffeine was used to assist with the depletion 
of intracellular stores for 5 min.  Then, the divalent-free solution was bath applied 
to replace any Ca2+ ions with sodium ions.  The Na+- ICRAC   was attenuated by 
bath application of AA (3 µM) in a DVF solution for 2 min following by a NCF 
solution containing AA to ensure that there were no AA-modulated currents 
evoked during the electrophysiological recordings involving AA.  
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Discussion 
 
 
 The outcome of this study supports the hypothesis that MOR activation 
and AA acid inhibit SOC channel activity.  Additionally, it is likely that opioid 
receptor activation exerts its inhibitory effects through the production of AA via a 
PTX-sensitive G-protein. Calcium imaging and electrophysiology confirms the 
hypothesis that MOR agonists inhibit SOC function and the ICRAC (Figures 3.1, 
3.6 and 3.7).    This finding along with studies that suggest SOC activity regulates 
action potential firing indicates that MOR activation may also suppress 
intracardiac neuronal function (DeHaven and Cuevas 2004).  While it has been 
firmly established that opioids exert their cardioinhibitory effects primarily via the 
CNS, studies involving intracoronary administration of opioid receptor antagonist 
naloxone suggest that opioids may operate more locally to modulate cardiac 
function (Caffrey, Gaugl et al. 1985).  Results in the current study and the fact 
that peripheral opioid concentrations spike in cases of congestive heart failure 
and circulatory shock   align with the results of the aforementioned study (Barlow, 
Deo et al. 2006; Vargish, Reynolds et al. 1980; Schadt and York 1981; Curtis and 
Lefer 1982).  
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Studies in rat amygdala pyramidal cells and in rat supraoptic nucleus 
neurons suggest that MOR activation changes excitability in these neurons 
through a PTX-sensitive G-protein therefore we hypothesize that MOR in 
intracardiac neurons may also be G-protein linked (Brown, Johnstone et al. 
2000).  In Figure 3.2 SOC activity was restored once the G-protein was 
inactivated suggesting that a PTX-sensitive peptide must be activated upstream 
of PLA2 induction.   
  Application of AA inhibitor, OBAA, was used in conjunction with 
receptor agonist treatment to ascertain whether PLA2 activation is a result of 
MOR activation.  A comparison of the percent block exhibited for the PSS control 
group and percent block for the groups pre-treated with the inhibitor before and 
after opioid application was established to account for any differences in basal 
SOC activity endogenous to the two groups.  In accordance with the current 
findings, AA production following opioid receptor activation has been discovered 
in rat amygdala pyramidal neurons.   Their studies also show, following receptor 
activation, Gi/o is activated and as a result PLA2 is induced (Faber and Sah 
2004). 
Furthermore, similar imaging experiments also show that application of 
30µM AA abolishes the SOC current induced following store depletion with TG; 
its effects were not readily reversible.  A normal PSS wash was unsuccessful in 
reversing Isoc depression; bovine serum albumin (BSA), which binds free fatty 
acids, was mandatory to restore normal channel activity without any direct effects 
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on the channel itself (data not shown).    Previous studies have shown similar 
inhibition of SOC activity with lower concentration therefore after a 10-fold 
decrease in AA concentration, effects were indeed reversible with a PSS wash 
(Rychkov, Litjens et al. 2005).  Similarly, the ICRAC was blocked following 6 µM AA 
application in rat intracardiac neurons.  Successive I-clamp electrophysiology 
studies would need to be performed to determine if there is a consequence on 
membrane properties of the neuron in the presence of AA.  However this finding 
is novel because, to date, it has not been displayed in excitable cells.   
Membrane phospholipid degradation is altered during myocardial ischemia 
shown by the alteration of fatty acid concentrations in vivo. Interestingly, AA and 
its precursor LA are both upregulated in cardiac tissue following ischemia and 
reperfusion. Therefore in Figure 3.4 A-B the essential dietary fatty acid was used 
to determine its effects on the intracardiac neurons that are closely associated 
with the myocardium.  LA blocked SOCE similar to AA which could suggest a 
compounded loss of function of the SOC channel than seen in the presence of 
AA alone during ischemic damage.   
Studies in guinea pig intracardiac ganglion show that prostaglandins, by- 
products of AA, alter the electrical activity of the neurons by attenuating the after-
hyperpolarization due in part to a decrease in small –conductance KCa2+ currents 
(Jelson, DeMasi et al. 2003).  It is also possible that AA and/or prostaglandins 
may be acting as a modulator of electrical activity by depression of SOC activity 
via direct channel binding. However in the current study, using the rat as the 
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model, we show that the identical prostaglandins used in the former investigation, 
in fact, do not modulate the SOC channels.  
There is evidence of a non-capacitative arachidonic acid-mediated current 
(IARC) existing in cell types such as fibroblasts and smooth muscle cells 
(Munaron, 1997; Broad, 1999). To ensure that no part of the mean peak current 
is due to a contribution of an IARC, we omitted the wash-out and inserted NCF 
with 3 µM AA into the conclusion of the time course (Figure 3.9).  Inhibition in the 
DVF solution by AA was similar (Figure 3.8), most importantly, when AA was 
introduced into the bath in a NCF solution there was no increase in the mean 
peak current. Therefore we conclude that the total current evoked in the DVF 
solution does not contain any AA-modulated current. 
  It has become evident that opiates exacerbate conditions such as shock 
(Holaday 1983; Liang, Imai et al. 1987), heart failure (Liang, Imai et al. 1987), 
and myocardial ischemia (Fagbemi, Lepran et al. 1982). However the exact 
mechanism by which this phenomenon occurs is unclear.  Electrophysiological 
studies would be necessary to confirm that modulation of SOC activity via MOR 
activation indeed compromises excitability, even though previous studies indicate 
that it is probable (Smith and Adams 1999). This study implicates two potent 
inhibitors of parasympathetic input to the heart that may be a part of a common 
pathway for inhibition of this critical local circuit.   
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CHAPTER 4 
 
NEUROCHEMICAL AND GENETIC DETERMINANTS OF EXCITABILITY OF 
INTRACARDIAC NEURONS 
 
INTRODUCTION 
 
There are a wide variety neuropeptides within the ganglia that control 
communication within the ganglia by modulating neurotransmitter release.   
Among these neuropeptides, cardiac met-enkephalin (ME) production is 
increased in spontaneous hypertensive rats (SHR) in comparison to 
normotensive rats (Dumont, Ouellette et al. 1991).  Similarly, the circulating 
levels of the peptide, endomorphin (EM), are increased in the ventricles of heart 
transplant patients (Ationu, Sorensen et al. 1993).  Given that both of these 
peptides activate µ-opioid receptors, the possibility exists that these peptides 
may affect cardiac function in diseased hearts.  It is therefore of interest to 
determine if µ-opioid receptor (MOR) activation can alter the function of 
intracardiac neurons and affect parasympathetic input to the heart.  Pituitary 
adenylate cyclase activating peptide (PACAP) which is found within the 
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mammalian intracardiac ganglion, promotes neuroexcitability through intracellular 
calcium mobilization in neurons from this ganglion (DeHaven and Cuevas 2004). 
In contrast, ME elicits elevations in intracellular calcium in intracardiac neurons 
by promoting Ca2+ release from intracellular stores (Smith and Adams 1999), but 
has been suggested to depress the excitability of these cells (Adams and 
Trequattrini 1998).  The study by Adams and Trequattrini, however, focused 
primarily on µ-opioid receptor regulation of N-type calcium channels (1998).  The 
effects on excitability were largely inferred by studies on single action potential 
firing (Adams and Trequattrini 1998).   
We have determined that there is a store-dependent, inwardly rectifying 
current that is carried by Na+ ions in the absence of extracellular calcium in 
individual neurons.    This current, ICRAC, is inhibited by the SOC antagonist, Gd3+ 
at exclusive concentrations as well as arachidonic acid, as shown in Chapter 3.    
The PLA2 –dependent free fatty acid has been also responsible for depression of 
the ISOC in rat liver cells and HEK293 cells (Rychkov, Litjens et al. 2005; Luo, 
Broad et al. 2001).   
The central hypothesis of this study is based upon the studies that report 
that both µ-opioid receptor agonists and AA are present in the heart at 
supranormal levels following a myocardical infarction and could be responsible 
for abnormal cardiac function through the alterations in intracellular calcium 
concentration (Barlow, Deo et al. 2006; Van der Vusse, Reneman et al. 1997).  In 
addition to AA and opioidergic agonists having analogous consequences on 
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cardiovascular function, there is also the possibility that they are a part of a 
common pathway in the intracardiac neuron, as observed in other excitable cell 
types such as periaqueductal grey and pyramidal neurons (Vaughan, Ingram et 
al. 1997; Faber and Sah 2004).   
   While this and other studies suggest that both AA and opioid receptor 
agonists have deleterious effects on Ca2+ channel conductance and the activity 
of excitable cells, the physiological consequences of SOC inhibition, specifically, 
by way of AA and µ-opioid activity in excitable cell types are unknown. This is not 
surprising considering the lack of conclusive information relating to SOC 
expression and function in neuronal cell types.   
Studies similar to the current examining modes of SOC modulation in 
excitable and non-excitable cell types are beginning to emerge.  The pore-
forming subunit of SOCs, the Orai protein was previously thought to absent in 
neuronal cell types.  Therefore, to date, there have not been any comparative 
assessments of Orai channel subunit expression among neuronal 
subpopulations partly because SOC-dependent modulation of excitability is a 
fairly novel concept.    Even though there are a plethora of factors that direct 
action potential discharge such as neurochemical influences and synaptic inputs, 
understanding ion channel protein expression is mandatory in assembling a 
comprehensive analysis of neuronal function.    
 There are individual morphologies associated with guinea pig intracardiac 
neurons: unipolar, mulitpolar, and bipolar termed S, SAH, and P, respectively.  
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Each cell type also has disparate electrophysiological profiles.  For instance, P 
cells display mostly tonic firing whereas S and SAH cell are more associated with 
either single or adaptive firing.  Relevant to the current study, there are two main 
electrophysiological subtypes of rat intracardiac ganglionic neurons, short (I) and 
prolonged after-hyperpolarizations
 
(II). Type I neurons are further subdivided  
 
 
into Ib  and  Im, based on the action potential bursts and multiple firing, 
respectively,  in response to prolonged membrane depolarizations.  Constituting 
only 8% of the ganglionic population, Type II neurons fire tonically, similar to Im.  
The exact mechanisms by which these neurons manifest these intrinsic firing 
patterns independent of factors such as neurotransmitter release have not been 
fully described. 
This study explores the possibility of Orai-SOC channel expression 
influencing endogenous firing patterns in neonatal rat intracardiac neurons.  
Orai1 or CRACM1, the pore-forming subunit of the CRAC channel, was 
discovered as a result of its central role in the pathology of severe combined 
immune deficiency (SCID).  T-cells expressing mutated Orai protein sequences 
are incapable of Ca2+-dependent activation, rendering the cells incapable of cell 
proliferation (Thompson, Mignen et al. 2009).     While the importance of Orai 
channel expression and functionality has been explored in immune cells, little is 
known about CRAC channel contribution to neuronal function.  The lack of 
information is due, in part, to the fact that VGCC have been viewed as the 
primary channels involved in Ca2+ entry into excitable cells.   
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Orai subunit expression differs among tissue types.   Orai1 and 3 are 
found predominately in lymphoid organs, skeletal muscle, hepatocytes, and skin 
(Gwack, Srikanth et al. 2008; Mignen, Thompson et al. 2008). Contrastingly, 
Orai2 is found mostly in the brain, kidney, lung and spleen (Gross, Wissenbach 
et al. 2007; Gwack, Srikanth et al. 2007).    However Orai expression among 
neuronal subpopulations remains a mystery.  Orai1 is capable of 
homodimerization and can assemble with Orai2 and Orai3 to form 
heteromultimers (Gwack, Srikanth et al. 2007).  On the other hand, only Orai1 
has been identified as functional in native cells.    
 Three Orai subunits each have different pharmacologies and biophysical 
properties.   Overexpression of Orai1 in HEK 293 cells yields 3-fold higher 
current amplitude and displays a more robust Ca2+-dependent inactivation than 
Orai2 and 3 expressed in the same cells.    Conversely, fast Ca2+-dependent 
inactivation is pronounced in cells overexpressing Orai3 while Orai1 and 2 
display more moderate fast Ca2+-dependent inactivation.     Furthermore, the 
SOC antagonist 2-aminoethoxyphenyl borate (2-APB) elicits its effects on Orai-
SOCs through multifaceted mechanisms including modulation of the intracellular 
Ca2+ sensor Stim as well as direct influences on Orai subunits.  Orai1 and 3 are 
potentiated through direct interactions in transfected HEK293 cells whereas 
Orai1 and Orai2- ICRAC currents are decreased in cells transfected Stim1.   This 
finding implies that the kinetics could vary considerably depending on subunit 
expression.   Considering the potential alterations channel expression could have 
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on cellular function, we must explore the possibility of modified cellular function 
with respect to subunit expression (Lis, Peinelt et al. 2007).   
 First, this study determines the possible contribution of SOCs to excitation 
of the neuron; second we used analogous experimental conditions to elucidate 
whether AA and opioid agonists alter action potential firing in dissociated 
intracardiac neurons.  Finally, this study serves as an electrophysiological and 
molecular study of the contribution Orai expression has on the innate electrical 
activity of intracardiac ganglionic neuronal subtypes.   
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METHODS 
 
Cell Culture 
All animals used in this study were Sprague-Dawley neonatal rats, 
sacrificed using rapid decapitation at 2-5 days old. All procedures were done in 
accordance with the regulations of the Institutional Animal Care and Use 
Committee.   Preparation and culture of neurons were followed as previously 
described (Fieber and Adams 1991).  Enzymatically dissociated neurons were 
fixed on poly-L-lysine coated coverslips and incubated for 2-5 days in 95% air 
and 5% CO2 at 37oC.  Following cell culture, isolated neurons were used for 
electrophysiological studies.   
 
Whole-Cell Patch Clamp Electrophysiology 
 Neurons from neonatal rats were enzymatically dissociated and mounted 
on poly-l-lysine coated coverslip as previously described.  The coverslips were 
transferred to the recording chamber of a phase contrast microscope (400X).    
Voltages were measured at room temperature in PSS: 140 mM NaCl, 3 mM KCl, 
2.5 MgCl2, glucose, 10 mM HEPES, and 2.5mM CaCl2.     Whole-cell perforated 
patch clamp technique was utilized as previously described to prevent loss of 
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cytoplasmic contents and preserve native physiological responses (Rae, Cooper 
et al. 1991; Xu and Adams 1992; Cuevas and Adams 1996).    The pipette filling 
solution contained (mM): 75 K2SO4, 55 KCl, 5 MgSO4, 10 Hepes, 198 µg/mL 
amphotericin B, and 0.4% DMSO.   The dialyzing method was used for PCR 
experiments; therefore amphotericin was omitted from the filling solution and 
action potentials were recorded no longer than 5 min following gaining electrical 
access (Cuevas, Harper et al. 1997).    Currents were amplified and filtered using 
an Axoclamp-200B Amplifier, digitized with a 1322A DigiData digitizer (20 kHZ), 
and collected.  Clampex 9 (Axon Instrumrents, Inc., Foster City, CA, USA). 
Clampfit, pClamp 9 program was used for analysis.  
 
 
Reagents and Statistical Analysis 
 
 The following drugs were used in this study: arachidonic acid (AA), 
(Alamone Labs, Jerusalem, Israel) endomorphin-1 (EM) and Gd3+ (Sigma),  Files 
were converted to text format and imported into SigmaPlot 11 and Clampfit  9.2  
for analysis.  Statistical analysis was performed by SigmaPlot using repeat 
measures One-Way ANOVA on Ranks non-parametric analysis, used for multiple 
group comparisons.    
 
Cytoplasm Harvest of Individual Neurons 
Cytoplasmic contents of individual neurons were isolated using negative 
pressure applied to the pipette following electrical recordings.  Pipettes were 
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filled with ~ 5 µL of filtered pipette solution.  Aspirated cellular contents were 
swiftly expelled by gently scraping the pipette tip along the side of the 
microcentrifuge tube and carefully applying positive pressure.  Individual neurons 
that were determined by electrophysiological recordings to be of the same 
subpopulation based on firing patterns (single, adapting, and tonic) were included 
in the same tube to pool and concentrate genetic material.  5-7 cells were 
included in every  isolation.   Due to the small amount of genetic material 
expected 1U RNase inhibitor (Promega, Madison, WI) was added to optimize 
yield.  
 
Quantitative Real-Time Reverse Transcriptase Polymerase Chain Reaction 
(qRT-PCR) 
 Gene transcripts were detected using qRT-PCR with Orai1, 2, and 3-
specific primers (Table 2) (Invitrogen).    Using the RNeasy mini kit (Qiagen, 
Mississauga, ON), RNA was isolated, purified, and used in a two-step reverse 
transcription and polymerase chain reactions.  The Sensiscript Reverse 
Transcriptase Kit (Qiagen, Mississauga, ON) for reverse transcription reactions 
of less than 50 ng of RNA was utilized to convert ~45ng of RNA to cDNA.  The 
oligo-dT priming method, more specific than the random hexamer, was used to 
hybridize and prime poly A tails of mRNA for transcription.   Per 20 µL reaction, 1 
µL Sensiscript reverse transcriptase, 1 µM oligo (dT) primer, 5 µM dNTP,  
Sensiscript reaction buffer and 1U RNase inhibitor (Promega, Madison, WI)  
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were added to water and allowed to incubate at 37oC for 60 min.  Gene 
amplification was achieved using the SYBR® Green JumpStart™ Taq ReadyMix™ 
(Sigma, St. Louis, MO) and 500 nM primers for each Orai gene. The reaction 
was performed in an Applied Biosystems StepOnePlus™ Real-Time PCR 
System (Foster City, CA) at 95oC for 15 min, followed by 60 cycles at 95oC for 1 
min and 53oC for 30s.   No template controls were included for each gene and 
melt curves yielded a single peak, indicating specific amplification.   Endogenous 
control, GAPDH was included to account for sample-to-sample variations in 
reaction performance and errors in sample quantification. 
 The comparative cycle threshold (Ct) method was employed to determine 
relative gene expression. Each reaction was performed in triplicate and mean 
cycle threshold values were determined. Mean delta cycle threshold (∆Ct) values 
are determined as the difference between the Ct value obtained from the GAPDH 
control sample for each neuronal subtype and the Ct value generated from the 
genes of interest (Orai1, Orai2, Orai3) for each neuronal subtype: 
 
 (∆Ct = Ct (Orai) – Ct (GAPDH))                                                  (Eq. 2) 
  
 Significance was determined using the repeat measures One-Way 
ANOVA on ranks non-parametric statistical analysis.   
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Table 2.  Specific primer sets for Orai 1, 2, and 3 (Ohana, Newell et al. 2009) 
Orai1 F: GACTGGATCGGCCAGAGTT 
R: GAGAGCAGAGCGGAGGTTC 
Orai2 F: CCGTGAGCAACATCCACA 
R: CAGCCAGGAAAAGCAGGA 
Orai3 F: CCACCAGTCACCACACCA 
R: CCAGCCCACCAAAACAAC 
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RESULTS 
 
Gadolinium Reduces Action Potential Firing at SOC-specific 
Concentrations 
   To determine whether action potential firing is SOC-dependent, we 
applied 5 µM Gd3+ to repetitively firing neurons.  Figure 4.1 shows representative 
traces of action potentials evoked in response to a depolarizing current pulse 
(500 ms, +100 pA)  before (Control), during (Gd3+) and after wash-out (Wash) of 
5 µM Gd3+ .   Quantitative data shows a reduction from 7.0 + 0.4 (Control) to   2.6 
+ 0.9 action potentials (Gd3+), then back to 4.2 + 1.8 upon wash-out of 
gadolinium.  The difference from control to drug-treated groups is statistically 
different.  Action potential discharge was appreciably reduced in the presence of 
5 µM Gd3.  Upon analysis of the single waveform, there seems to be no effect on 
the after-hyperpolarization upon application of Gd3+, however the action potential 
amplitude was increased (Figure 4.1C).  
  
Tonic Action Potential Firing is Attenuated upon µ-Opioid Receptor 
Activation        
We used whole-cell perforated patch clamp electrophysiology in the 
current clamp mode to investigate whether opioid agonist, EM-1, has any effect 
on action potential firing. Figure 4.2A shows a family of voltage responses 
elicited by 500 msec, +100 pA depolarizing current pulses from a single neuron.  
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Voltage changes were recorded in the absence (Control), presence (EM-1) and 
following wash-out (Wash) of 1 µM EM.    EM blocked action potential firing 
appreciably and the inhibitory effects were easily reversible upon wash-out. The 
opioid agonist reduced the mean number of action potentials from 3.6 + 0.7 
under control conditions to 1.4 + 0.6 in the presence of the drug.  Following 
wash-out action potential firing was restored to 2.9 + 0.7 demonstrating the 
reversibility of the drug (Figure 4.2).  The single action potential waveform 
remained unchanged following EM treatment (Figure 4.2C).   
 
Arachidonic Acid Inhibits Repetitive Action Potential Firing in Rat 
Intracardiac Neurons 
 The central hypothesis of this study predicates that µ-opioid receptor 
activation leads to AA production and subsequently, SOCE inhibition. To test 
whether AA has any influence on tonic firing, we used the whole-cell patch clamp 
in the perforated patch clamp configuration in current clamp mode to evoke 
action potentials by using depolarizing current pulses (500 ms, +100 pA).  In 
Figure 4.3, action potential traces recorded before (Control), during (AA) and 
following wash-out (Wash) of 3 µM AA are shown.     
Prior to AA application, the neurons fired 3.6 + 0.2 mean action potentials.  
However following a 5 min application of AA, this mean number decreased 
significantly to 1.2 + 0.4 and following a 5 min wash-out of the free fatty acid, the 
neurons fired a mean number of 3.0 + 0.8 action potentials over the same 
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amount of time.  There is an increase in the after-hyperpolarization and decrease 
in the amplitude when the single action potential waveforms are transposed upon 
one another for analysis.  
 
 
Action Potential Firing is Dependent upon Orai Subtype Expression 
Previous electrophysiological studies suggest that there is a Ca2+ store-
dependent  component to action potential firing in neonatal rat intracardiac 
neurons.   We hypothesize that differences in intrinsic firing patterns may be 
attributed to differences in Orai subunit expression.  We used RT-PCR to 
determine whether variations in Orai subunit expression contribute to differences 
in firing patterns.  Following eletrophysiological data collection, RNA was 
extracted and purified from neurons.  RNA from neurons displaying similar firing 
patterns was reverse transcribed into cDNA.  Then, the cDNA template from 
each of the experimental groups, single, adapting, and repetitively firing neurons, 
was submitted to separtate qRT-PCR reactions.  Specific primers (Table 2) were 
used to determine the relative levels of mRNA expression of Orai1, 2, and 3.    
Contrastingly,  Orai3 mRNA expression was relatively low for single and adating 
neurons  for each isolation (n=3).    For tonically firing neurons,  Orai3 mRNA 
transcripts were high when compared to the other two neuronal subtypes. 
However subunit expression combinations were inconsistent among the 
isolations (n=3).  We can conclude that tonically firing neurons are unique in that 
they express elevated Orai3 mRNA (Figure 4.4).      
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Figure 4.1 Low-dose Gadolinium Blocks Action Potential Firing. Representative 
traces of action potential bursts recorded from a single cell in response to 500 ms, 
+100 pA current pulses before (Control, black trace), during (Gadolinium, red trace) 
and following washout (Wash, blue trace) of 5 µM gadolinium (A). Bar graph of the 
mean number of action potentials + SEM recorded from 5 neurons under identical 
conditions as in A (B).  Asterisk denotes significant difference from control group 
(p<0.05).) Single action potential wave forms before (Control, black trace), during 
(Gadolinium, red trace) and following washout (Wash, blue trace) of gadolinium (C).   
Electrical access was achieved using the perforated patch configuration of the whole 
cell technique. 
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Figure 4.2 Tonic Action Potential Firing is attenuated Upon MOR Activation    
Representative traces of action potential bursts recorded from a single cell 
in response to 500 ms, +100 pA current pulses before (Control, black 
trace), during (EM), red trace) and following washout (Wash, blue trace) of 
1 µM endomorphin-1 (A). Bar graph of the mean number of action 
potentials +SEM recorded from 5 neurons under identical conditions as in 
A (B).  Asterisk denotes significant difference from control group (p<0.05).   
Single action potential wave forms before (Control, black trace), during 
(EM, red trace) and following washout (Wash, blue trace) of EM(C).     
Electrical access was achieved using the perforated patch configuration of 
the whole cell technique.  
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Figure 4.3 AA Inhibits Repetitive Action Potential Firing. Representative 
traces of action potential bursts recorded from a single cell in response to 
500 ms, +100 pA current pulses before (Control, black trace), during (AA, 
red trace) and following washout (Wash, blue trace) of 3 µM arachidonic 
acid (A) . Bar graph of the mean number of action potentials + SEM 
recorded from 5 neurons under identical conditions as in A (B).  Asterisks 
denotes significant difference from control group (p<0.05).  Single action 
potential wave forms before (Control, black trace), during (AA, red trace) 
and following washout (Wash, blue trace) of the fatty acid (C).   Electrical 
access was achieved using the perforated patch configuration of the whole 
cell technique. 
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Figure 4.4 Comparative qRT-PCR Results Orai 1, 2, and 3 mRNA expression 
for Single, Adapting, and Multiple Firing Neurons. Mean ∆Ct values were 
determined from ∆Ct values from 3 separate RNA extractions for each neuronal 
subtype.  Asterisk denotes significant difference of Orai3 subtype mRNA 
expression from the multiple firing group in comparison to the other neuronal 
subtypes (p<0.05).   
* 
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Discussion 
 
The main discovery of this study is, first, that store-operated calcium 
channels contribute to repetitive action potential firing.  Second, AA and EM both 
decrease the number of action potentials fired per unit time in cardiac neurons.  
These findings suggest that the reduction of SOC activity via the activation of a 
µ-opioid receptor-mediated pathway has the ability to affect the electrical 
properties of the neuron.  This study is novel because most of the previous 
studies of SOCs and their consequences on cellular physiology are in non-
excitable cell types.   Now we can begin to fully understand the functional 
significance and mechanism of action of SOCs in the modulation of action 
potential firing not only in intracardiac neurons but all excitable cell types.  
 The most accepted antagonist for SOCE, Gd3+ at low micromolar 
concentrations, was able to reduce action potential firing which suggests that 
SOC channels have at least some contribution to action potential firing.  We may 
exclude the possibility of the VGCC blockade because of their decreased 
sensitivity to Gd3+.  Our lab has shown that Gd3+ at low micromolar 
concentrations (1 -10 µM) is able to reduce capacitative calcium entry in a dose 
dependent manner (unpublished data). Also, it has been shown to block action 
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potential firing in baroreceptor neurons at millimolar concentrations through the 
inhibition of stretch-activated ion channels (Hajduczok, Chapleau et al. 1994).  
Future studies of the effects on possible SOC-dependent action potential firing 
may include other direct SOC antagonists such as 2-APB and SKF-96365 
because these antagonists have been proven to be responsible for the inhibition 
of CCE.  Store-dependent calcium entry is due to the interaction of an 
endoplasmic reticulum associated protein, Stim, to the Orai subunit.  Therefore 
Stim1 antagonist ML-9 may be used in current-clamp experiments as an indirect 
method of testing SOC effects on action potential firing.  
 Interestingly Cd2+-induced blockade of voltage dependent Ca2+ channels 
reduced the after-hyperpolarization peak but not the duration of the AHP of the 
action potential; which suggests that there may be an unidentified calcium source 
in neonatal rat intracardiac neurons (Franciolini, Hogg et al. 2001).  It is our 
hypothesis that SOCs are likely to be the calcium source that is responsible for 
the maintenance of repetitive firing in mammalian intrinsic cardiac neurons.  
There is evidence that intracellular calcium oscillations, that is, movement across 
that endoplasmic reticulum and plasma membranes by SOCs, particularly, lead 
to long-term repetitive action potential firing (Kusters, Dernison et al. 2005). 
These results are analogous to those seen as a result of EM-induced µ-
opioid receptor activation in the supraoptic nucleus (SON), nucleus tractus 
solitarius (NTS) and dorsal motor nucleus of the vagus (DMV) (Doi, Brown et al. 
2001; Glatzer, Derbenev et al. 2007).   It is important to note, relevant to the 
103 
 
current study, that the intracadiac ganglia receives input from the CNS from the 
DMV  therefore it would be likely that EM would play an analogous inhibitory role 
in the cardiac ganglia.   
In addition to Gd3+, the consequences of EM and AA on repetitive firing 
are examined in this study as a part of the central hypothesis which claims that 
EM-induced attenuation of intrinsic cardiac neuronal activity is a result of the 
direct action of AA.  To test the validity of this theory, EM and AA were applied at 
concentrations that were shown to block SOCE in imaging experiments, 1µM and 
6µM, respectively.    Both blocked repetitive firing appreciably, which supports 
the original hypothesis.  
  Using qRT-PCR we found that Orai2 was expressed most frequently 
across multiple RNA isolations, consistently in single and adapting neuronal 
subtypes, which concurs with previous studies that report Orai2 as being the 
most abundant in murine brain cells (Gwack, Srikanth et al. 2007).  However, a 
separate study purports mRNA Orai3 only as commonly expressed in human 
brain cells (Gwack, Srikanth et al. 2007).    Orai3 was expressed at high levels in 
repetitive firing primary neonatal rat intracardiac neurons in comparison to the 
other subtypes.  Proper control of calcium cycling is needed to avoid apoptosis 
and maintain firing frequency, in the case of excitable cell types.  Initiated by 
Ca2+in the vicinity (3-4nM) of the pore the calcium channel, Ca2+-dependent 
inactivation is a negative feedback mechanism which limits global calcium 
overload (Zweifach and Lewis 1995; Frischauf, Muik et al. 2009).   Fast Ca2+-
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dependent inactivation is most pronounced for the Orai3-ICRAC in comparison to 
the remaining two subtypes.     Orai1- ICRAC is unique in that it displays slow 
reactivation whereas Orai2- ICRAC and Orai3- ICRAC exhibit subsequent slow 
inactivation (Lis, Peinelt et al. 2007).  Therefore SOC- dependent action potential 
firing may be dependent on its inactivation. Using a quantitative model, Kusters 
et al. demonstrates a SOC-dependent model in the maintenance of intracellular 
calcium cycling and action potential firing (2005).  Furthermore, it has been 
proposed that fast inactivation of SOCs serves to diminish the role of fast Ca2+-
activated K+ currents in the Ca2+ oscillation mechanism by reducing the voltage 
gated calcium component of calcium entry during the after-hyperpolarization 
(Zweifach and Lewis 1995).     
  V-clamp experiments would need to be performed to definitively assess 
the contribution of various SOC inactivations on excitability in these primary 
cultured neurons. As most of the previous studies involve expression systems,   
the results may vary greatly. Intracellular calcium sensor, Stim interacts with Orai 
subunits to activate SOCs and exists in two different species, Stim1 and 2. The 
current study does not take into account differences in Stim expression. 
Therefore when interpreting the results presented here, one must keep in mind 
that Stim1 alone or in combination with Stim2 could also be playing a role in 
SOC-dependent action potential firing. The limitations associated with this study 
may help explain inconsistent molecular data within the experimental groups.  
However it maintains its significance in that it exists as the first of its kind to 
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determine the potential effect of protein expression, namely a non-voltage 
activated calcium channel, on action potential discharge within parasympathetic 
subtypes (Won, Whang et al. 2006). 
 The neurohumoral component plays a central role in the regulation of the 
activity of these ganglia and these neuropeptides function in altering the 
membrane properties of individual neurons through their differential influences on 
Ca2+ channels (Adams and Trequattrini 1998; DeHaven and Cuevas 2004). Each 
Orai subunit has distinct biophysical properties; therefore we hypothesize that 
differences in expression may contribute uniquely to the action potential 
waveform, namely the AHP via large conductance calcium-activated potassium 
channel (BKCa2+), and ultimately firing frequency. 
Serving as the final common circuit for the processing of parasympathetic 
input, the mammalian intracardiac ganglia exists as a very intricate network of 
postganglionic neurons within the cardiac nerve plexus.  There are 
intraganglionic as well as interganglionic connections that orchestrate this 
integration as well as providing a local means for regulation of the end organ. In 
disease states such as congestive heart failure, proper integration of this 
information becomes disrupted, having deleterious effects on cardiac function.  
The likelihood of this study having overwhelming implications in the pathology of 
heart failure is small considering the complex architecture and neurochemistry 
associated with these ganglia that may also be influencing firing frequencies.    
However these findings could provide information towards the subsequent 
106 
 
exploration of Orai channels of the cardiac plexus and their regulatory 
mechanisms as potential therapeutic targets for heart failure. 
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CHAPTER 5 
 
 
SUMMARY 
 
 
The data presented here serve as a comprehensive study of the 
contribution store-operated calcium channels (SOCs) have to neuronal activity 
along with the consequences of opioidergic regulation of SOC channels.  While 
an excitatory pathway involving SOC activity has been described in the 
modulation of intracardiac neurons (DeHaven and Cuevas 2004), this study 
offers an inhibitory mode of regulation for SOC channels mediated by µ-opioid 
receptor (MOR) activation.  Furthermore, a comparative study was conducted to 
determine the link between Orai expression and action potential discharge. We 
concluded that repetitive firing may be dependent upon Orai3 expression within 
intracardiac neuronal subpopulations. 
 The current study is motivated by previous work elucidating the effects of 
various ganglionic neuropeptides on cellular function.  Cuevas and Adams found 
that VIP potentiates ACh-evoked currents in rat intracardiac neurons via 
activation of a PTX-sensitive G-protein (1996).  Contrary to previous studies that 
claim cAMP is produced following Gs recruitment in neural and ephithelial cells, 
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the study was also able to determine that diffusible second messenger cAMP 
was not activated following vasointestinal polypeptide (VIP) receptor activation 
in rat neonatal parasympathetic neurons. In order to study single channel 
conductance, the study utilized excised membrane patch experiments.  Outside-
out membrane patches involve the detachment of small sections of the 
membrane with the outside of the membrane facing away from the electrode to 
allow the evaluation of single channel properties.   This electrophysiological 
method revealed that VIP augments the ACh receptor channel open probability. 
This phenomenon is thought to be responsible for the effects of VIP on cardiac 
function (Cuevas and Adams 1996).    Modulating nicotinic cholinergic receptors 
(nAChRs), VIP and pituitary adenylate cyclase-activating peptide (PACAP) 
initiate pathways that have a common G-protein (Go) in common.  Using 
PACAP6-38, a PAC1 and VPAC2 antagonist, this group also found that VIP 
elicits its synergistic effects via its binding to the VPAC1 receptor (Liu, Cuevas et 
al. 2000).   Contrastingly, exogenous VIP enhances muscarinic synaptic 
transmission and excitatory responses within superior cervical ganglia 
(Kawatani, Rutigliano et al. 1985).   
One study in particular done by our lab, explores the effects of cardiac 
peptides VIP and PACAP on neuronal function and the mechanisms by which 
they exert their effects.    The study concluded that PACAP and VIP promoted 
action potential firing via a mechanism dependent on the mobilization of calcium 
from intracellular stores.  Using fura-2 calcium imaging, a biphasic response 
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could be observed, intracellular store release followed by an influx into the 
cellular cytosol.  The latter phenomenon was suggestive of store-operated 
calcium entry.  
 In a recent study, muscarinic and nicotinic cholinergic receptors have 
differential effects on calcium mobilization.  The Adams group shows 
pharmacologically that the nACh elicits an ionotropic response involving calcium 
influx and subsequent calcium-induced calcium release (CICR) from ryanodine-
sensitive stores.  On the other hand, mACh induces a metabotropic response 
that initiates phospholipase C (PLC), leading to the activation of 
phosphatidylinositol 4,5-bisphosphate (PIP2), and production of IP3 and DAG.  
The intracellular second messenger responsible Ca2+ mobilization from the ER, 
IP3 binds to the IP3 receptor channel. At this point, Ca2+, now cytoplasmic as 
opposed to membrane bound, rapidly activates Ca2+-dependent K+ channels 
before being buffered by the mitochondria or actively resubmitted into the ER via 
Ca2+-ATPase pump (Beker, Weber et al. 2003).  Similiary, µ-opioid receptor 
agonists have been implicated in the production of inositol trisphosphate (IP3) to 
have similar effects on calcium mobilization in rat intracardiac neurons (Smith 
and Adams, 1999).                    
 Previous studies confirm that of the five muscarinic receptor subtypes, 
mRNA transcripts for M1-M4 are present in rat and guinea pig (Hassall, Stanford 
et al. 1993; Hoover, Baisden et al. 1994). Interestingly, chiefly parasympathetic, 
the intracardiac neuron is capable of coexpressing more subtypes of the 
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muscarinic receptor than any other native cell type.  Furthermore, 
electrophysiological studies confirm that M4 receptor activation, specifically, 
modulates voltage-gated calcium channel activity via a PTX-sensitive G-protein  
(Cuevas and Adams 1997).  Analogous to outcomes reported here, studies 
previous to the latter suggest that muscarinic receptor modulation occurs 
through mechanisms that exclude prokein kinase C (PKC), diacylglcerol (DAG), 
and adenylate cyclase (AC) (Xu and Adams 1993).  Also, the M1 receptor has 
been implicated in the inhibition of  Im in a variety of autonomic neuronal types 
(Bernheim, Mathie et al. 1992; Cuevas and Adams 1997; Xi-Moy and Dun 
1995). Whereas K+ channel activity is suppressed following M2 receptor 
activation in rat intracardiac neurons through G-protein coupled mechanisms 
which concurs with signaling cascades that result in the inhibition of the SOC 
(Allen and Burnstock 1990; Xi-Moy, Randall et al. 1993). 
  Vasointestinal pituitary adenylate cyclase (VPAC1) and pituitary adenylate 
cyclase (PAC2) receptor activation has been shown to modulate intracellular 
kinases such as protein kinase A (PKA) and protein kinase C (PKC), 
respectively, in certain cell types.  In addition, NetPhosK 1.0 predicted PKA and 
PKC binding sites on the Orai1 subunit.   Therefore we hypothesized that these 
kinases, along with cAMP, have an influence on CCE.  Using calcium imaging, 
we measured changes in neuronal [Ca2+]i  before and after incubation in 1 µM 
phorbol 12, 13 dibutyrate (PDBu)  using  a conventional calcium add back 
protocol following passive store depletion by thapsigargin (TG).     The PKC 
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activator did not induce any appreciable deviations in ∆[Ca2+]i from the control 
group.  Similarly, membrane permeable cAMP analog, 8-Br-cAMP and, 
adenylate cyclase (AC) activator, forskolin did not influence SOCE upon Ca2+ 
add back.  Both cAMP and AC are a part of a common pathway to PKA 
activation therefore we have concluded that PKA does not have an effect on 
Orai-SOC channels.    
Much variability exists in regard to the reported influences of kinases on 
capacitative calcium entry (CCE).  The differences are largely dependent upon 
cell type and the kinase subtype.  Mechanistically, the conflicts could be due to 
indirect effects on the plasma membrane-bound channel by store-depletion. In 
the present study, Ca2+ stores are depleted prior to drug treatment to ensure that 
all effects are direct.  However, this study is the first to examine kinase-regulated 
SOC activity in excitable cell types and subsequent experiments are required to 
fully describe the absolute consequences of kinase activity.     Opioid agonist, 
met-enkphalin depletes IP3 sensitive stores as well as   blocks N-type voltage-
gated calcium channels (VGCCs) in intracardiac neurons, specifically (Adams 
and Trequattrini 1998; Smith and Adams 1999). Therefore, we hypothesized that 
MOR agonists may have an effect on CCE.  To test this hypothesis, we 
employed the add back protocol as previously described, before and after 10 µM 
ME and EM applications (Figure 3.1).  As a result, we were able to conclude that 
opioiderigic activation potently inhibits CCE in rat intracardiac neurons.   
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This finding is paramount considering that enkephalins have been found to 
be a component of the neurochemical profile of the intracardiac ganglionic 
neurons. However, the methods by which these peptides modulate cellular 
function have not been fully described. While the data presented here provides 
only a singular component of the composite effects of opioidergic activity within 
intracardiac ganglia, this study is based on the novel premise that SOCs are 
expressed in neuronal subtypes as opposed to non-excitable cell types and are 
functional and capable of modulation by cardiac peptides.  There are a plethora 
of reports citing opioidergic inhibition of VGCCs (Jessell 1977; Wilding, Womack 
et al. 1995; Adams and Trequattrini 1998). However prior to the present study, no 
information concerning SOCs and opioidergic signaling has existed.   
Following MOR activation, an intracellualar signaling pathway is initiated, 
having direct effects on the channel protein subunit.  In NG-108 cells 
overexpressing MOR receptors, PTX was able to attenuate EM-induced 
depression of VGCCs, indicating   G-protein coupling.  To elucidate whether a 
PTX-sensitive G-protein is activated as a result of ligand binding, cells were pre-
treated with PTX before applying EM.  PTX was able to prevent EM-induced 
SOCE, proving that a Gi/o protein becomes active in response to opioid peptide 
interacting with the MOR.  Similarly, in amygdala pyramidal neurons, it has been 
shown that a PTX-sensitive G-protein linked to the MOR receptor causes the 
activation of PLA2 (Faber and Sah 2004). 
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  We concluded that there may be a possibility that PLA2 may be a second 
messenger in the signaling cascade currently under investigation.  First we used 
the ketone, AACOCF3 to bind and antagonize PLA2 prior to MOR recruitment 
(data not shown). However, we found that the AA analogue had direct effects on 
CCE.  Therefore we decided to use OBAA a potent, structurally disparate PLA2 
inhibitor that does not exhibit direct effects (Kohler, Friedrich et al. 1991).   Both   
agents were able to attenuate percent inhibition of SOCE due to MOR activity 
(Figure 3.1).   These findings suggest that the PLA2 plays a central role in 
eliciting MOR-induced reduction in calcium influx following ER depletion.  
 PLA2 is the key enzyme responsible for phospholipid membrane cleavage 
in the production of AA; it is then probable that AA is a subsequent second 
messenger in this particular intracellular pathway.  An AA-induced decrease in 
mean peak SOC currents has been documented in rat liver cells. Therefore 
using calcium imaging, I tested the probability that AA could have similar 
consequences on CCE in neonatal rat intracardiac neurons.   AA was applied to 
cells following passive store-depletion with TG in zero Ca2+.  AA attenuated 
[Ca2+]I  increases upon addition of 2.5 mM Ca2+ to the bath.  During this 
investigation, we observed that the two lipids AA and its analogue AACOCF3 
had negative consequences on the SOC channel.  Therefore LA was presented 
to the neurons to elucidate further whether the lipid structure was responsible for 
this inhibitory phenomenon.  In the same manner, LA was able to block the 
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activity of the channel indicative of a lipid-protein interaction, detrimental to 
channel function. 
 Along with neural control, the intracardiac ganglia are capable of control 
by immune responses. Secreted by interganglionic mast cells, prostaglandins, 
which are AA metabolites, are a class of immune mediators that elicit rapid 
modulation of the electrical properties of neighboring neurons (Jelson, DeMasi 
et al. 2003).  Two prostaglandin isoforms in particular, PGE2 and PGD2, reduced 
the after-hyperpolarization duration and amplitude via the attenuation of the 
small-conductance K+ channels (SKCa2+).  However whether they have direct 
effects or indirect effects via Ca2+ has not been determined although 
prostaglandins have been previously reported to attenuate Ca2+ channels in 
other neuronal preparations  (Mo, Ammari et al. 1985; Ikeda 1992; Ito, Murai et 
al. 2000).    
 We explored the possibility that this phenomenon may be due to inhibition 
of SOCs using the add back protocol as previously described.  In the presence of 
both PGE2 and PGD2, there was no difference in ∆[Ca2+]i from control values. 
Therefore we concluded that these particular prostaglandin subtypes do not have 
an influence on SOCE in rat intracardiac neurons.  It is important to note that 
differences between the rat and the guinea pig should be considered when 
making a comparison between any physiological systems because of the 
evolutionary hypoxic  Andean environment of the guinea pig (Turek, Ringnalda et 
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al. 1980). Therefore one must be cautious when establishing function 
correlations between the two animal models.   
 The initial portion of this study used calcium imaging as a tool to assess 
the effects of MOR agonists and second messengers in our proposed inhibitory 
pathway on CCE.  We have proven that   MOR-specific agonists EM and ME 
both depress SOC activity following G-protein recruitment.  The G-protein is 
responsible for activating PLA2, which subsequently cleaves AA from the plasma 
membrane to directly interact with the SOC channel.   
 Using calcium imaging, we assessed the effects of the MOR-mediated 
pathway on SOCE through intracellular calcium elevations following store 
depletion. However, in order to make a complete assessment we must consider 
the Ca2+ current evoked across the plasma membrane in response to store 
depletion, ICRAC.     A relatively small current, the ICRAC is blocked at low nM 
calcium concentrations; however it is highly selectively for Ca2+ ions.  Some 
other biophysical properties of the ICRAC are that it is potentiated when Ca2+ is 
completely removed from the bath solution and evoked in response to store 
depletion by caffeine and EGTA.  Using the appropriate pipette and bath 
solutions to detect the ICRAC, I studied the consequences of our proposed 
inhibitory signaling cascade on ICRAC using the V-clamp mode of whole cell patch 
clamp electrophysiology.    
 Enkephalins have been shown to block voltage dependent calcium 
currents and ME blocks VGCC in rat neonatal intracardiac neurons, specifically 
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(Jessell 1977; Wilding, Womack et al. 1995; Xiao, Spurgeon et al. 1993; Adams 
and Trequattrini 1998).  First, we determined whether EM had a similar effect on 
ICRAC as the voltage-dependent calcium current and CCE. After store-depletion 
by 10 mM caffeine, a - 160 pA current was evoked in a divalent free (DVF) 
solution. However when 1 µM EM was introduced to the bath, this current was 
reduced to about - 95 pA (Figure 3.6).     Similarly, 10 µM ME was able to 
depress the ICRAC from -225 pA to -75 pA. In both instances, this effect was 
readily reversible upon a DVF physiological saline solution PSS wash (Figure 
3.7).  These findings are evidence that MOR activity is responsible for a 
common inhibitory thread extending from VGCCs to SOC channels and provide 
an explanation for the neurosuppression that occurs following release of these 
peptides within the mammalian heart.  
 Next, we used our proposed model created in accordance with the 
imaging results to predict that AA would behave similar to the EM and ME in the 
control of SOCs.  Additionally, AA has been shown to inhibit ISOC in rat liver cells 
(Rychkov, Litjens et al. 2005).   To test this hypothesis, we applied our protocol 
as previously described in the case of EM and ME in the V-clamp 
electrophysiological studies.  AA was able to attenuate the ICRAC by two-thirds 
upon bath application (Figure 3.8), an outcome which is analogous to the results 
obtained from the imaging experiments presented previously.   
 While AA causes a reduction in this capacitative Ca2+ current, a non-
capacitative Ca2+ current has been identified that is modulated by AA, IARC, 
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arachidonic acid regulated current.  Interestingly, IARC seems to be evolutionarily 
related yet functionally distinct from other types of calcium channels 
(Shuttleworth 2009).  In order to differentiate between the IARC and ICRAC in the 
current study, AA in a NCF PSS was added to the bath following AA-induced 
inhibition of the ICRAC. There was no subsequent current evoked in NCF solution 
therefore we have concluded that the current evoked is purely due to calcium 
release (Figure 3.9).   Taken together, these electrophysiological 
experiments concur with the results of fura-2 calcium experiments that indicate a 
MOR-initiated signaling cascade consisting of the production of intracellular 
second messengers, leading to SOC inhibition.   Electrophysiology provides a 
more precise method which CCE can be studied because we are able to control 
precisely the ionic environment according to the biophysical properties of the 
SOC channel.  By studying the changes in mean peak current densities in 
response to drug bath application, this method offers a more exact and 
conclusive method of studying Orai-SOCs,  in particular.   
 Next we asked: Does this current play a functional role in the regulation of 
electrical activity of the neuron? The question under investigation is very unique 
considering that no other Ca2+ channel aside from VGCC currents has been 
found to be integral in the modulation of the membrane properties of the neuron.     
However, results of previous studies have suggested VGCCs are not 
responsible for modifications in the after-hyperpolarization (AHP) in rat 
intracardiac neurons (Franciolini, Hogg et al. 2001).  To explore the possibility of 
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the involvement of SOCs, we used the most SOC-specific antagonist, 5 µM 
Gd3+, to elucidate its influences on repetitive firing in dissociated neonatal rat 
intrinsic cardiac neurons.  Using the I-clamp mode of the perforated patch 
configuration of patch clamp electrophysiology, we have shown that multiple 
action potential firing is converted to adaptive firing in the presence of 5 µM 
Gd3+, which is indicative of SOC-dependent control of action potential discharge 
in these neurons.     Experiments similar to these using other SOC antagonists 
such as SKF-96365 should be performed to confirm Orai-SOC suppression as 
Gd3+ is a promiscuous antagonist of cationic channels. However the current 
results definitely justify further investigation of the potential role of SOCs as 
regulators of membrane properties of the neuron.   
 We repeated the same I-clamp experiment with EM to determine whether 
EM would block action potential (AP) firing similarly.   EM was effective in 
reducing action potential firing appreciably from 3.6 + 0.6 to 1.4 + 0.6.  The 
results of our calcium imaging and V-clamp electrophysiology experiments with 
AA indicate first, that AA suppresses SOCE as well as the ICRAC in intracardiac 
neurons.  We therefore predicted that AP firing will be suppressed upon 
application of AA.   Next, we applied the same protocol to elucidate the effects of 
AA on AP discharge and found that AP firing was reduced from tonic to adaptive 
firing. 
 So far, we have established that a MOR-mediated pathway is capable of 
eliciting a potent reduction of repetitive firing through the ICRAC.   However the 
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molecular composition of these channels has not been identified in this or any 
other neuronal subtype.  Furthermore, no prior information exists on the 
molecular contribution of the individual channel subunits to cell excitability 
because Ca2+ regulation of membrane properties has been attributed to the 
activity of VGCCs.  This study is novel in that its hypothesis is based on recent 
studies that indicate there is an alternative source of Ca2+ in these ganglionic 
neurons and this source is calcium release-activated not voltage-dependent.   
 Using I-clamp electrophysiology and RT-PCR, we found that Orai3 was 
present in comparably high levels in multiple firing neurons (Figure 4.4).  The 
fact the Orai3 is associated with robust Ca2+- dependent fast inactivation, 
exclusively, suggests that repetitively firing neurons display more robust fast- 
inactivation of SOCE than single and adaptive firing neurons (Lis, Peinelt et al. 
2007).  
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CONCLUSIONS 
 
In several cardiac disease states, such as congestive heart failure (CHF) 
and post-myocardial infarction arrhythmias, decreased parasympathetic and 
increased sympathetic tones are observed resulting in sudden cardiac death.  
The final common pathway for autonomic regulation of the heart, the mammalian 
intracardiac ganglia serve as a major integration center for all parasympathetic 
inputs into the heart and are capable of local control over the heart independently 
of the CNS. However studies in the canine model indicate that this local control is 
compromised in the case of CHF.   Contemporary studies indicate that the 
intracardiac ganglia function within the cardiac plexus as a key player in a series 
of nested feedback loops rather than linearly.  The loss of parasympathetic 
control in the case of heart failure, particularly, is at the level of the intracardiac 
ganglia.    
Due to the complex architecture of the cardiac nervous system, 
intracardiac neurons are able to play both a causative as well as an effector role 
in progression and development of cardiac dysfunction.   For instance, cardiac 
neurons promote coronary vasodilation and dysregulation of coronary blood flow 
in disease states.  Furthermore, changes in intracardiac neuronal function are 
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observed following myocardial ischemia.  Considering the integral role the 
parasympathetic autonomic nervous system plays in the maintenance of proper 
cardiac function, the amount of information that exists within the current literature 
pertaining to its exact mechanisms of regulation are deficient.    It is through 
these studies that we are able to devise pharmacological agents to safely and 
effectively treat certain cardiac diseases.     
The most commonly prescribed pharmacological therapy for CHF in 
particular, digoxin, elicits its negative chronotropic effects by facilitating 
parasympathetic tone to the heart (Khand, Rankin et al. 2003; Gheorghiade, 
Adams et al. 2004).      Extreme caution must be practiced when prescribing 
digitalis because of the narrow therapeutic window associated with digitalis. 
Consequently, the development of alternative therapeutic agents is necessary to 
facilitate safe and effective management of critical cardiac disease states.  
The complexity of the neurocircuitry as well as the neurochemistry of 
these ganglia demands comprehensive studies of its modes of regulation in the 
complete assessment of its contribution to cardiac function.  Along with changes 
in neural transmission, there are also changes in the neurohumoral component of 
the intrinsic cardiac ganglia associated with an array of cardiac conditions.  
Relevant to the current study, cardiac opioid and enkephalin production is 
transformed in an array of diseases such as cardiomyopathy, heart failure, and 
genetic hypertension resulting in disease progression.  Additionally, in the dog, 
the severity and incidence of cardiac arrhythmias were attenuated following 
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opioid receptor antagonism. The mechanisms by which these peptides exert their 
effects are poorly understood.   The conclusions attained in the current endeavor 
align with those that claim MOR stimulation is responsible for the inhibition of 
VGCCs in parasympathetic neurons of the nucleus ambiguus and the superior 
cervical ganglionic neurons.      Therefore, this study may provide additional 
insight into a possible method by which these peptides cause detrimental 
alterations to cardiac physiology.  
Experiments executed here are paramount in that they contribute to the 
understanding of a voltage-independent source of calcium to excitable cells, 
because SOC channels were previously thought to be restricted to non-excitable 
cell types. We prove that Orai-SOC channels, particularly, are not only expressed 
but they are indeed functional in a neuronal cell and contribute appreciably to 
cellular excitability. The comparative evaluation of molecular and 
electrophysiological properties serves as the first to establish a link between Orai 
expression and membrane properties within neuronal subtypes. Furthermore, our 
observations in intracardiac neurons could pioneer similar research on store-
operated methods of calcium regulation in other neuronal types.   Future studies 
would reveal additional modes of modulation for these channels and could lead 
to unique, new pharmacological interventions as that target the regulation of 
intracellular calcium concentrations.    
Our proposed pathway indicates AA as the singular and direct second 
messenger leading to SOC antagonism.  Considering the fact that AA is 
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upregulated following ischemia and reperfusion in vitro, the phospholipid could 
lead to disruption of normal autonomic function independent of MOR activity 
therefore the implications for potential therapies are compounded in this respect.   
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APPENDIX 1: 
LIST OF ABBREVIATIONS 
 
2-APB - aminoethoxydiphenyl borate  
OBAA - 4-4- Octadecylalkybenzoylacrylic acid  
ACh - acetylcholine  
AC - adenylate cyclase  
AHP - after-hyperpolarization  
AA - arachidonic acid  
AV - atrioventricular  
BSA - bovine serum albumin  
KCa2+ - calcium-dependent potassium channels  
ICRAC - calcium release-activated current  
CICR - calcium-induced calcium release  
CaM - calmodulin  
CCE - capacitative calcium entry  
ChAT - choline acetyl transferase  
CHF - congestive heart failure  
cAMP - cyclic adenosine monophosphate  
DAG - diacylglcerol  
DMSO - dimethyl sulfoxide  
DVF - divalent-free   
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DMN - dorsal motor nucleus  
P - efferent postganglionic neurons  
EM - endomorphin  
HF - heart failure  
HVA - high voltage –activated 
IP3 - inositol trisphosphate  
IN - interneurons  
[Ca2+]i - intracellular calcium concentrations  
BKCa2+ - large conductance calcium-activated potassium channel  
LA - linoleic acid  
ME - met-enkephalin  
MLCK - myosin light-chain kinase  
mAChRs – muscarinic cholinergic receptors 
nAChRs - nicotinic cholinergic receptors  
nAChRs - nominally calcium free (NCF) 
NA - nucleus ambiguus  
NCF-nominally calcium-free 
NTS - nucleus tractus solitarius  
PDBu - phorbol 12, 13 dibutyrate  
PIP2 - phosphatidylinositol 4,5-bisphosphate  
PLA2 - phospholipase A2  
PLC - phospholipase C  
PSS - physiological saline solution  
PAC - pituitary adenylate cyclase  
PACAP - pituitary adenylate cyclase-activating peptide   
PGD2 - prostaglandin D2  
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PGE2 -prostaglandin E2  
PKA - protein kinase A  
PKC - protein kinase C  
ROS - reactive oxygen species  
ROCCs - receptor-operated calcium channels  
SCID - severe combined immune deficiency  
SA - sinoatrial  
SIF - small, intensely fluorescent cells  
SKCa2+ - small-conductance calcium channels  
SOCs - store-operated calcium channels  
SOCE - store-operated calcium entry  
SON - supraoptic nucleus  
TG - thapsigargin  
VIP - vasoactive intestinal polypeptide  
VPAC - vasointestinal pituitary adenylate cyclase receptor  
VGCCs - voltage-gated calcium channels  
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